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PREFACE 
 
Recently, doctors have been increasingly seeing 
biomineralization in their practice. It is observed primarily in 
patients with impaired metabolism. However, sometimes the 
manifestations of increased biomineralization of various organs 
and tissues in patients are quite unexpected for the clinician. This 
causes complexity in the treatment, prognosis of the disease. As 
a result, there is a need for a thorough study and understanding 
of this pathological process. Thanks to the introduction of 
modern morphological, physico-technical methods of research 
in medicine, the diagnostics of the process of tissue 
biomineralization in various pathological processes have 
significantly improved. Today, significant progress has been 
made in the study and understanding of this biological 
phenomenon in living and dead tissues in various pathologies, 
but many questions remain. One of them – biomineralization – 
is a positive or negative process in the human body. There are 
enough publications in the literature that clarify 
biomineralization from different positions for a living organism. 
It is our work that addresses these issues, which will allow us to 
open the veil of a complex living organism that is struggling with 
various pathological processes, especially with tumor growth. 
Our work is based on fundamental studies of biomineralization 
in the laboratories of Sumy State University (Ukraine) and Umeå 
University (Sweden). We hope that the results of our research 
will be useful for all specialists who are interested in the study 
of complex bioprocesses in living organisms. 
 
 
Head of the Department of Pathology,  
Sumy State University,  
Doctor of Medical Sciences, Prof. A. M. Romaniuk 
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LIST OF SYMBOLS AND ABBREVIATIONS 
 
АV – aortal valve. 
АFМ – atomic force microscopy.  
BHP – benign hyperplasia of prostate. 
СА – corpora amylacea or amyloid bodies in prostate. 
Casp-3 – caspase 3. 
ChCCh – chronical calculous cholecystite. 
CIC – circulating inflammatory cells. 
CAV – calcified aortic valves. 
CHD – coronary hearth disease. 
GB – gallbladder. 
GC – gallbladder carcinoma. 
ЕC – endothelial cells. 
ІHC – immunihistochemistry. 
ІRS – infrared spectroscopy. 
JCPDS – Joint Committee on Powder Diffraction Standards 
MPO – myeloperoxidase. 
MTT– malignant thyroid tumor. 
MV – microvesicles. 
OPG – osteoprotegerine. 
OPN – osteopontine. 
VC – vascular calcification. 
PB – psammoma bodies. 
PPi - pyrophosphate mineralization inhibitor. 
PBM – pathological biomineralization. 
PBG – porcelain gallbladder. 
PTC – papillary thyroid carcinoma. 
SEM – scanning electronic microscopy. 
TEM – transparent electronic microscopy. 
TNSALP - tissue nonspecific alkaline phosphatase. 
TG – thyroid carcinoma. 
VSMC – vascular smooth muscle cell.  
XRD – X-ray diffraction. 
6 
 
INTRODUCTION 
 
In recent decades, the interest in the study of pathological 
biomineralization in the human body has increased significantly. 
This is due to a significant increase in the incidence of pathology 
associated with this phenomenon [1, 2, 3]. 
Biomineralization is the process of formation of minerals 
by living organisms under the conditions of formation and 
growth of biominerals from a supersaturated aqueous solution in 
an organic matrix having a cellular origin [4]. In living 
organisms, biomineralization develops into three types: silicon, 
carbonate, and phosphate. Today, about 300 biominerals are 
known [5]. 
Biophysical, biochemical and pathogenetic features of 
biomineralization under conditions of internal and external 
adverse factors have not been sufficiently studied. Data from 
scientific literature regarding the influence of exo- and 
endogenous factors on the initiation and development of 
pathological biomineralization (PBM) processes are 
controversial. Regeneration and repair possibilities of body 
tissues under conditions of development of PBM processes 
remain a little researched question. It is important to find ways 
to treat and prevent pathological biomineralization. 
A considerable amount of new scientific data and facts 
about pathological biomineralization have appeared in the 
literature. Due to the rapid development of molecular biology, 
biochemistry, pathological physiology and morphology, the 
introduction of new research methods into medical practice, the 
view on the traditional division of pathological mineralization or 
mineral dystrophy into metastatic, dystrophic and metabolic is 
changing. The active nature of this process and the similarity of 
mineral dystrophy to the physiological processes of 
biomineralization in solid tissues of the body become evident. 
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Therefore, despite a large amount of new knowledge 
about the mechanisms and nature of pathological 
biomineralization of soft tissues, there is no clear answer as to 
the direction, clinical, morphological and prognostic 
significance of it under different pathological processes, such as 
benign and malignant tumor growth, chronic inflammation, 
dystrophy and atherosclerosis. 
This research was performed as part of the investigation 
topics of Pathology Department of Sumy State University № 
0117U003937 "Development of diagnostic method of the 
reproductive system tumors using cellular adhesion molecules 
of the cancer-embryonic antigen" and № 0118U003570 
"Efficiency of liquid biopsy and tissue biopsy in the malignant 
tumors diagnostic and treatment". 
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1 SOFT TISSUE BIOMINERALIZATION 
 
1.1 Brief historical sketch of the development  
of biomineralogy 
The development of biomineralogy as a science is 
divided into two main stages: the period of formation of science, 
which lasted until the middle of the twentieth century, and the 
period of existence as a separate branch of scientific knowledge 
[6]. 
In the first period of development of biomineralogy there 
was an accumulation of data on the structure, composition, 
genesis of biominerals. Biomineralization has been a process for 
over one billion years. Formation of the first biominerals began 
in the Precambrian and continues to this day, accompanying the 
evolutionary development of living organisms [5]. One of the 
first modern scientists to pay attention to the problems of 
biomineralization was academician V.I. Vernadsky in the 20's of 
the twentieth century. On the territory of the former USSR, the 
term "biomineralogy" was first used by A. Korago in 1976 in a 
work devoted to the study of river pearls [6]. The first work, 
where the term "biomineralogy" was used in the name, was 
published in Kyiv, a monograph by B. I. Srebnodolsky 
"Biological mineralogy" in 1983, which was devoted to 
mineralization processes in the body of animals [7]. A 
significant event in the development of this science was the 
publication of the fundamental work "Introduction to 
Biomineralogy" in 1992 by A. Korago [6]. Now biomineralogy 
is a field of scientific knowledge that is on the border of various 
sciences and is rapidly developing. This issue is covered by a 
number of foreign specialized journals and conferences 
(Calcified Tissue Int, Eur J of Mineralization, Bone, Journal of 
Crystal Growth). 
The process of biominerals research is complicated by 
the complex interaction of the organic and mineral components 
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that make up them. The organic and mineral components of 
biominerals are inextricably linked and interact under certain 
laws, which is why the term "organic-mineral aggregates" 
(OMA) has been consolidated [8]. Biominerals or OMA of the 
human body are divided into physiological and pathological. 
 
Figure 1.1 – Biomineralization in the human body 
 
1.2 Physiological biomineralization 
In the body of a healthy person, physiological 
biomineralization is limited by the solid tissues of the oral 
cavity, the skeleton, the equilibrium organ (otoliths), and the 
brain epiphysis tissue (the deposition of "brain sand"). 
Teeth. Teeth include mineralized tissues such as enamel, 
dentin and cement. In the human body, the most mineralized 
tissue is tooth enamel, the mineralization of which is 95-97 % of 
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its weight [9, 10]. Dentin, which forms the major part of the solid 
tissues of the tooth, has 72 % of inorganic substances, the major 
part of which corresponds to the hydroxyapatite mineral [11]. 
Cement wraps around the root of the tooth and is involved in 
attaching the tooth to the alveolar bone. It is slightly softer than 
dentin and is composed of  
45-50 % inorganic substances (hydroxyapatite). In addition to 
hydroxyapatite, the basis of the mineral tissues of the teeth is 
octacalphosphate and in small quantities other forms of apatites 
– carboxyapatite, chlorapatite, strontium apatite and fluorapatite 
[12]. 
Bones. There are approximately 270 bones in the human 
body [13]. Bone is by nature a relatively lightweight and durable 
composite material containing inorganic and organic parts. The 
bone mineral component reaches 60-70 % of the weight and is 
also mainly composed of hydroxyapatite [13, 14]. The organic 
part of the bone is represented mainly by collagen, an elastic 
protein that provides resistance to fractures [14]. In addition to 
collagen, which are structural proteins, a significant proportion 
of bone proteins are regulators of the biomineralization process: 
osteopontin, osteonectin, osteocalcin, bone sialoprotein, and 
phosphor dentin [15]. In bones, mineralization begins with a 
heterogeneous solution of calcium and phosphorus ions. Mineral 
nucleates are generated in the empty spaces between the 
collagen fibers in the form of a thin layer of hydroxyapatite, 
which grows to fill the available space. However, the mechanism 
of deposition of minerals in the organic part of the bone even 
today is not fully understood and studied [15]. 
Brain sand or corpora arenacea of the pineal gland. In 
the pineal gland or epiphysis there are mineralized structures, the 
number of which increases with age – the so-called corpora 
arenacea (or "acervuli," or "brain sand"). These formations have 
a layered structure (hence the name – corpora arenacea) and 
festoon edges. Their sizes range from 5 microns to 2 mm and 
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resemble a mulberry berry in shape [16]. Chemical analysis of 
calcified cones of the pineal gland shows that they consist of 
compounds of calcium phosphate: hydroxyapatite, β-TCMF 
(beta-tricalcium-magnesium phosphate) [17]. There is also 
evidence of calcite in the "brain sand" [18]. 
The corpora arenacea of the epiphysis often serve as an 
anatomical reference point in the radiological examination of the 
head in patients after 30-40 years, since their number increases 
significantly with age [16]. The mechanisms of formation and 
function of "brain sand" are unknown. Some studies indicate that 
Alzheimer's patients have a significantly higher level of 
epiphysis calcification than other types of dementia [18]. It has 
also been found that with age, the pineal gland contains the same 
amount of fluoride as the teeth. In addition, there is a correlation 
of calcium and fluorine content in the epiphysis [17]. 
Otoliths. The inner ear contains minerals that are called 
otoliths or statocones and are part of the body of equilibrium. 
Otoliths have been found in all vertebrates and in parts of 
invertebrates, including many extinct creatures [19]. Statoconias 
in mammalian equilibrium organs are represented by elongated 
(10x1-3 μm) calcite crystals [20]. Otoliths can be products of 
cell secretory activity. Their displacement when changing the 
position of the body and the impact of acceleration causes 
mechanical irritation of the hair cells and the appearance of the 
corresponding nerve impulses [19]. 
 
1.3 Pathological biomineralization 
The term "diseases of biomineralization" (calcification, 
pathological biomineralization, calcinosis, mineral dystrophy) 
includes such nosologies as deposition of calcium minerals in 
the walls of vessels and cardiac valves, cholera-, nephro-, sialo, 
prostatolithiasis, calcification of nodes in the thyroid gland, 
uterus, mineralization phenomena in almost all soft tissues of the 
body [5, 21, 22, 23, 24, 25, 26, 27]. The presence of biomineral 
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deposits that develop as a result of the development of a 
pathological process always has a significant impact on the 
development, course and consequence of a disease. In addition, 
this effect can be not only negative - in the form of complications 
of the disease with unfavorable prognosis, but also protective, 
that is, one that prevents dangerous or fatal complications or 
softens the course of the main nosology. 
Depending on the localization in the human body 
biomineral formation has its morphogenetic and pathogenetic 
features. One of the most frequent localizations of pathological 
biomineralization is the cardiovascular system [25-27]. Other 
common nosologies include gallstone disease, nephrolithiasis, 
thyroid pathology, and prostatolithiasis. Often, biominerals are 
postponed in the lungs, salivary glands, oral and nasal cavities, 
much less likely to damage the organ of vision. The formation 
of calcifications in the tissue of tumors should be noted 
separately. 
Cardiovascular calcification. In the cardiovascular 
system, PBM is most commonly found in complicated 
atherosclerosis (atherosclerotic plaques with calcification in the 
aorta, blood vessels, and cardiac valves), Menkenberg 
arteriosclerosis, phleboliths [28, 29]. Organo-mineral aggregates 
of calcium compounds formed on cardiac valves are called 
cardiolites in some literature [5, 8]. The greatest clinical and 
socio-economic importance is the PBM, which complicates the 
course of atherosclerosis. Cardiovascular calcification is 
considered an important predictor of morbidity and mortality in 
atherosclerotic vascular lesions [25, 29]. 
Recent works had raised the question that different forms 
of biomineralization in vessels have different biological 
properties and clinical behaviour [30]. Such PBM pattern as 
"microcalcification" is characterized by chronic inflammation in 
the pathological focus and the risk of atherosclerotic plaque 
rupture. On the other hand, the formation of large leaf-like 
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calcifications in the aorta, blood vessels, and heart valves 
corresponds to the pattern of PBM "macrocalcification", which 
in contrast, stabilizes the atherosclerotic plaque and serves as a 
barrier to inflammation [30]. 
Hydroxyapatite is the preferred mineral for 
cardiovascular PBM [29, 31]. 
Gallbladder. In the gallbladder (GB), mineral formation 
occurs not only in its cavity, but also in the walls - in cases of 
such nosologies as porcelain gallbladder or gallbladder cancer 
[32]. 
More common pathology is cholelithiasis, with the 
formation of stones in the organ cavity with organic and 
inorganic component. A favorable environment for the 
formation of stones is a violation of the composition of bile and 
a number of diseases of the GB and biliary tract [5]. The organic 
constituent of gallstones is represented by cholesterol, bilirubin 
and biliverdin (pigment stones). The inorganic part of the stones 
contained the following calcium-containing minerals: 
carbonates (faterite, aragonite, calcite, dolomite), phosphates 
(velocity). Pigments with high calcium content are particularly 
important - palmitate and calcium bilirubin, which are white and 
black in color [5]. 
The mineral component of the GB wall under conditions 
such pathology as porcelain gallbladder (PGB) was represented 
by hydroxyapatite [33]. Perhaps this is due to different 
conditions of mineral formation in the cavity and wall of the GB. 
Kidney and bladder calculus stones. The basis for the 
formation of kidney stones and the urinary system is the 
violation of urinary homeostasis due to a number of diseases and 
the influence of external (mainly dietary) factors [34]. The 
formation of concrements is facilitated by an increase in the 
concentration of inorganic phosphorus (> 75 mmol / l), total 
calcium (> 7 mmol / l), magnesium (> 5 mmol / l), oxalic acid 
(> 0.25 mmol / l) and uric acid (> 4 mmol / l) in the urine. A 
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significant influence on the formation of minerals in the urinary 
system is fluctuations in pH. Thus, the daily average pH of a 
healthy person fluctuates within 5.5-6.5, under conditions of 
formation of oxalate stones the pH fluctuates within 4.8-7.0; in 
the conditions of urate - 4,5-5,8; under the conditions of 
phosphate - 6,0-7,7 [35]. The most common in the urinary 
system are oxalate stones (uevelite minerals, weddellite), 
phosphate stones (minerals struvite, hydroxyapatite, brucite, 
whitlockite) and urates (minerals uricite, uric acid dihydrate and 
ammonium urate) [35]. 
Pathological biomineralization of the thyroid gland. In 
the thyroid gland, calcifications occur in both benign and 
malignant tumor pathology [36]. Among all thyroid diseases, 
calcification is most commonly found in papillary thyroid cancer 
(PTC) [37, 38]. Based on the clinical features of pathologic 
biomineralization, Bai Y. et al. (2009), PTC calcifications were 
divided into psammoma bodies (PB), stromal calcification, and 
ectopic bone formation (ossification) [39]. PBs are characterized 
as spherical calcified cells, which are constructed of concentric 
plates and are an important diagnostic criterion for papillary 
thyroid cancer [36, 40, 41]. Ossification or bone formation was 
recorded in cases where the bone matrix and osteocytes were 
identified. All calcifications that did not fit the definition of PB 
and ossification were considered stromal calcification [39]. In 
addition to PTC, PBM is found in nodal (follicular and 
medullary cancer, nodular goiter, adenomas) and diffuse thyroid 
pathology (autoimmune thyroiditis, thyrotoxicosis) [36]. 
Typically, in these cases, the capsule of the nodes, the walls of 
the vessels, the stroma and the colloid of the follicles are subject 
to calcification. Hydroxyapatite mineral formation is 
characteristic for PBM of thyroid gland [37, 41, 42]. 
Prostatic lithiasis (prostatoliths). Ectopic mineral 
formation in the prostate gland can be realized due to the 
influence of such etiological factors as chronic inflammation, 
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congestive phenomena in the gland, urinary reflux from the 
urethra with intravesical obstruction, malformation of the 
prostate gland and seminal vesicles; specific inflammation, 
deficiency of protein-inhibitors of calcification. Prostatoliths are 
found in the alveolar glands and ducts of the prostate. According 
to a number of studies, including our own observations, 
hydroxyapatite is the predominant mineral among prostatoliths 
[43]. Some studies indicate that there are also oxalates among 
prostatoliths [44]. 
 
Sialolites and dentolites. The conception and formation 
of the salivary gland and dentolite stones are significantly 
influenced by saliva composition and parameters of saliva and 
inflammatory processes (sialoadenitis, caries). Sialolites and 
dentolites are characterized by similar morphology and 
chemical-phase composition. These biominerals have a 
concentric-layered structure: uneven layers of inorganic matter 
are separated by thin layers of organic matter [10]. The form of 
sialoliths is often determined by the structure of the salivary 
gland apparatus and its excretory ducts. With regard to the 
crystal-chemical composition of sialolites and dentolites, in 
addition to the predominant hydroxyapatite, there are also other 
phosphates of calcium - brushite, octacalphosphate and 
whitlockite [10, 11]. 
Pulmolites. Pulmonary alveolar microlithiasis (PAM) is 
a rare disease characterized by intra-alveolar deposits of calcium 
compounds as small round stones [46]. The etiology of the 
disease is still unknown, it is suggested that the cause is a 
hereditary defect of enzymes, since a large part of the PAM 
(about a third) has a family heredity [47]. PAM is characterized 
by the presence of many small nodules, calcified cells along the 
interparticle septa, bronchial-vascular bundles and pleural 
lesions in the form of fibrosis, subpleural cysts [46]. PBM in 
lung tissue often occurs as a result of tuberculosis (Ghon's 
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focus), chronic inflammation, and as a result of diffuse 
pulmonary calcification (DPC) [48]. DPC is observed in 
hyperparathyroidism, chronic renal failure, vitamin D 
intoxication, but has never occurred in the absence of other 
diseases. In other words, this disease meets the definition of 
metastatic lung calcification [48]. 
Ophthalmolites. PBM in the organ of vision is extremely 
rare. Among the ophthalmic pathology that is accompanied by 
mineralization can be called choroidal osteoma, idiopathic 
choroidal sclerosis, tophus-like scleral calcification, intraocular 
bone metaplasia and calcification in chronic inflammatory 
diseases [49]. The structure of biominerals and their phase 
composition was investigated in chronic inflammatory diseases. 
It was found that the main mineral component is hydroxyapatite 
with a defective lattice and small crystal sizes [49]. 
Rhinoliths. Mineralized objects in the nasal cavity are 
called rhinoliths [50]. They often form around foreign bodies or 
blood clots. In some cases, it is not possible to detect a foreign 
body in the nasal stone [51]. Occasionally rhinoliths are 
confused with osteomas of the nasal cavity, which are derived 
from the bones of the nasal sinuses. 
According to the literature and our own observations, 
biomineralized nasal cavities are composed of calcium 
phosphate (hydroxyapatite), representing calcified detritus [52]. 
PBM in malignant tumors. Biominerals are closely 
related to secondary changes in tumor tissues, the presence of 
necrosis or necrobiosis foci. The large number of dead cells is a 
source of phosphates and calcium, which creates the conditions 
for the formation of minerals of the calcium phosphate group, 
mainly apatites [53]. Postpone of calcium deposits also occurs 
around the tumor node (in adjacent tissue), vascular walls, and 
lymph nodes [36, 53]. This type of PBM differs from classical 
dystrophic calcification. A specific type of tumor-associated 
PBM is PB, which is a characteristic diagnostic feature of some 
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tumors (PTC, papillary ovarian carcinoma, meningioma) [54]. 
The features of the occurrence, formation and biological 
behaviour of PB also distinguish them from the manifestations 
of dystrophic calcification [36, 55]. 
The behaviour of osteotropic metastases of various 
malignant tumors is also interesting. There are two types of 
metastatic bone lesions: osteolytic and osteoblastic metastases 
[56]. Osteolytic metastases are characterized by the dissolution 
of the mineral component of bone, which can lead to 
pathological fractures, osteoporosis, hypercalcemia. 
Conversely, osteoblastic metastases result in a tightening of the 
bone mineral tissue, which slows the spread of the tumor. Such 
tumors have a more favorable clinical course and prognosis [56]. 
Perhaps the main regulatory role in this process belongs to the 
cells of bone tissue - osteoblasts, whose function is enhanced 
under conditions of osteoblastic metastases. 
An important component of physiological and 
pathological biomineralization is the organic-mineral aggregate. 
The interaction between the organic and mineral parts of the 
OMA is governed by certain laws. On the example of 
physiological biominerals, the mechanism of formation has been 
well studied, the regulatory function of the organic (protein) part 
of OMA (cells, activator molecules, and biomineralization 
inhibitors) has been established [57]. 
 
1.4 The concept of the "niche of biomineralization" 
When studying the processes of biomineralization in soft 
tissues, there is a realization that the forming of biominerals is a 
complex open physicochemical system that interacts with the 
whole organism. This system consists of cells, non-cellular 
elements (stromal elements), molecular and metabolic 
nanoenvironment of biomineralization processes. The 
physicochemical environment of biomineralization includes 
elements of the circulatory system, the acidity of the medium, 
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the level of substrates (phosphorus, calcium, protons, carbon 
dioxide), hydrostatic pressure, the presence/absence of an 
appropriate matrix, oxygen level, enzymatic supply, regulatory 
(cytokine) supply or, maybe, elements of nerve regulation. The 
combination of all these elements forms a "biomineralization 
niche", in which there is a complex multicyclic process of 
formation of biominerals in the tissues of living organisms 
(Fig. 1.2). 
 
 
Figure 1.2 – Scheme of "niche biomineralization" 
 in soft tissues 
 
1.5 Cellular microenvironment of biominerals 
In healthy people, the process of physiological mineral 
formation is limited by specialized tissues such as the skeleton 
and teeth. Throughout life, the formation of mineral tissue and 
calcium-phosphorus homeostasis are under the strict control of 
various regulatory systems of the body. For example, a change 
in the concentration of calcium ions in the serum even by 1 % 
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immediately leads to mechanisms that restore its equilibrium 
[5]. 
Cells - sources of mineralization in the vascular wall and 
soft tissues come from several precursors. These include 
resident half-stem cells, circulating mesenchymal cells from 
bone marrow stroma, subendothelial pericyte-like cells, vascular 
mesenchymal cells (also known as calcifying vascular cells), 
adventitious myofibroblasts, smooth myocytes (SMC - mature 
and immature), endothelial cells. The last two cells can be 
transformed into osteoblastic cells by epithelial-mesenchymal 
transformation [58]. 
Also known is intra-membrane ossification, which 
occurs in the case of direct mineralization of the matrix of 
mesenchymal cells that undergo osteogenic differentiation. 
However, endochondral ossification occurs in cartilage as an 
intermediate stage of mineralization [14]. For example, with the 
growth of long bone plates, chondrocytes take the place of future 
bone tissue, creating a gradient of chondrocytes at the stages of 
bone maturation: proliferation, pre-hypertrophy, hypertrophy, 
and apoptosis. Apoptotic bodies act as nucleation centres of 
calcium phosphate crystals produced by calcified cartilage, 
which acts as a matrix where microvessels grow, bringing 
endothelial cells and pericytes [59]. 
Also known is intra-membrane ossification, which 
occurs in the case of direct mineralization of the matrix of 
mesenchymal cells that undergo osteogenic differentiation. 
However, endochondral ossification occurs in cartilage as an 
intermediate stage of mineralization [14]. For example, with the 
growth of long bone plates, chondrocytes take the place of future 
bone tissue, creating a gradient of chondrocytes at the stages of 
bone maturation: proliferation, pre-hypertrophy, hypertrophy, 
and apoptosis. Apoptotic bodies act as nucleation centres of 
calcium phosphate crystals produced by calcified cartilage, 
which acts as a matrix where microvessels grow, bringing 
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endothelial cells and pericytes [59]. Chondroclasts, which 
derived from monocytes, dissolve calcified cartilage. The 
pericytes of the microcirculatory bed (MCB) under the influence 
of the calcified matrix and its components undergo osteogenic 
differentiation. Thus, osteogenic cells formed from pericytes 
become the source of bone matrix formation, osteons, matrix 
vesicles (MV), new crystals of hydroxyapatite that replace 
cartilage. Endotheliocytes and pericytes, upon maturation into 
osteoblasts or chondrocytes, begin to express 
"osteochondrogenic" genes and secrete MV in the extracellular 
matrix. The transformative effect of hydroxyapatite crystals on 
pericytes and vascular smooth muscle cell (VSMC), which in 
their presence acquire osteoblastic differentiation, was also 
found [60, 61]. 
Matrix vesicles. Initiation of calcification occurs inside 
the matrix vesicles (MV), extracellular entities originating from 
the cell membrane [62]. Calcified MV contain high levels of 
Ca2+, which is bound to acidic phospholipids, 
phosphatidylserine and membrane phosphatases (including 
tissue nonspecific alkaline phosphatase (TNSALP). They 
hydrolyze various esters of phosphoric acid of natural origin, 
which eventually gives rise to the formation of calcium-
phosphate minerals. The inner microenvironment surrounded by 
the membrane protects the nuclei of the mineralization in the 
pre-crystallization state before converting them to 
hydroxyapatite. With the rest, MV merge with the already 
existing crystals of hydroxyapatite, which leads to further 
mineralization [63]. 
There are several mechanisms for the formation of MV. 
MV was first described by Clark X Andersen in 1967 in the form 
of buds on degenerate cell membranes in bone matrix and bone 
cell cultures [64]. Subsequently, similar formations were found 
in other tissues, including blood vessels and cultures of 
endothelial cells, dendritic cells, and smooth myocytes [59]. 
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They have been called different terms - extracellular vesicles, 
apoptotic bodies and microvesicles [65]. The composition of 
MB VSMC was thoroughly investigated and compared with MB 
of skeletal tissues. The molecular composition of MV of 
different origin, consisting of alkaline phosphatase, a 
considerable number of annexins and calcium minerals in the 
nucleation state, has been established [59, 65]. In the study of 
pathologic mineralization in atherosclerotic plaques, the 
possibility of MV formation by macrophages and possibly other 
inflammatory cells has recently been identified [15, 66]. 
 
1.6 Molecular nanoenvironment: pro- and anti-calcifying 
effects 
Alkaline phosphatase and PHOSPHO1. TNSALP is a 
phosphatase that destroys a pyrophosphate mineralization 
inhibitor (PPi) [67, 68]. An additional phosphatase, 
PHOSPHO1, was recently detected in MV [69, 70]. In the 
absence of PHOSPHO1 deficiency, skeletal abnormalities, 
osteomalacia, and decreased TNSALP and PP levels appear in 
experimental mice [71]. In PHOSPHO1 deficient mice, 
TNSALP overexpression does not correct skeletal 
mineralization, regardless of correction of PPI level, since 
skeletal mineralization is completely absent in mutant 
PHOSPHO1 and TNSALP mice [70]. Therefore, it can be 
assumed that PHOSPHO1 is not a backup initiator of 
biomineralization. It has also been experimentally demonstrated 
in vitro that pharmacological inhibition of PHOSPHO1 in 
VSMC slows down matrix mineralization [69]. 
Ectonucleotide pyrophosphatase / phosphodiesterase 
(ENPP1). Ectonucleotide pyrophosphatase/phosphodiesterase 
(ENPP1) is a transmembrane glycoprotein that helps regulate 
bone and cartilage mineralization through the production of 
inorganic phosphate [10]. Based on the results of the study of 
animals with a double gene knockout of TNSALP and ENPP1, 
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it was found that these two enzymes are important for the 
balance of activity of other mineralization factors. Double 
knockout of the genes of these proteins corrects the deviations 
in biomineralization that occur in the event of simple damage (e. 
g., deletion) of the gene of each of them. ENPP1 functions as a 
maker of pyrophosphate mineralization inhibitors and under the 
influence of reducing the activity of alkaline phosphatase, a 
generator of extracellular inorganic phosphate (due to 
phosphodiesterase activity), which promotes the growth of 
crystals of minerals [71]. 
Gamma-carboxyglutamic acid matrix protein (MGP). A 
small MGP protein has been identified as a key inhibitor of 
vascular mineralization [72, 73]. It is known that in the absence 
or deficiency of this protein, mice develop rapid and clear 
vascular calcification [74]. It is believed that MGP can bind to 
bone-forming proteins (BMPs) and/or directly to calcium 
minerals. The rapid development of pathological 
biomineralization in the absence of MGP is explained by the 
non-alternative effect of BMP on the expression of genes 
responsible for osteoblastic cell differentiation. The formation 
of minerals is potentiated by endocytosis of calcium phosphate 
nanocrystals, which has an inductive influence on 
osteochondrogenic genes [75]. 
An interesting feature of MGP is its dependence on 
vitamin K, which is involved in post-translational modification 
by gamma-glutamyl carboxylation [76]. This is confirmed by 
the fact that warfarin, which blocks the activity of vitamin K, 
enhances ectopic biomineralization [77]. 
The matrix γ-carboxy glutaric acid protein is the first 
time obtained from the bone. To become fully functional, it 
requires vitamin K-dependent γ-carboxylation, but it is non-
carboxylated MGP associated with vascular calcification. By 
binding to BMP-2, MGP blocks its activity against osteoblastic 
differentiation of VSMCs and differentiation of mesenchymal 
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cells. MGP also contacts to crystals of calcium salts and inhibits 
their growth [76]. Together with fetuin, they act as crucial 
regulators of the evolution of membrane-associated matrix 
vesicles [78]. 
Fetuin A (Heremans-Schmid α2 protein). Fetuin A is a 
calcium-binding protein that is produced mainly in the liver. 
Mice with an absent gene of fetuin A demonstrate the 
development of massive calcification of the lungs, blood vessels, 
and other tissues that somehow bypasses the aorta. Fetuin A 
globulin is a transporter of sex hormones in the blood that may 
be associated with climax and subsequent onset of progressive 
biomineralization. Whereas MGP, osteopontine (OPN), and 
osteoprotegerin (OPG) are local factors, fetuin A is a significant 
"systemic" circulating inhibitor of vascular calcification [79]. 
VSMCs are capable of incorporating serum fetuin A and 
depositing it in intracellular, membrane-bound matrix vesicles. 
They are released by cells into the matrix and become centres of 
crystallization of minerals there, but not when they are rich by 
fetuin A. Fetuin A, in combination with insoluble crystals, is 
called calcium-protein particles (CPP) in some studies [79-80 ]. 
The incorporation of fetuin A into the MMC is enhanced by 
extracellular calcium but not by extracellular phosphates. The 
entry of this protein into smooth myocytes (SMC) increases Ca2+ 
flow in them and is mediated by the activity of calcium channel 
annexin, which facilitates the inhibitory role of fetuin A on the 
mineralization of SMC [79]. Mice that do not produce fetuin A 
develop microcalcifications in small vessels and increase the 
deposition of calcium compounds in soft tissues [66]. 
Receptors of nuclear activator of nuclear factor kappa-
B ligand (RANKL) and OPG. RANKL is a key factor in the 
resorptive osteoclastic activity that is triggered by lipid 
peroxidation products (LPO). OPG is a receptor-bait for 
RANKL, otherwise known as osteoclastogenesis inhibitory 
factor (OCIF). OPG belongs to the tumor necrosis factor (TNF) 
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family and is a cytokine receptor [81]. Activation of RANKL in 
vascular MMCs of mice occurs through the osteogenic 
differentiation factor Runx2 in a dose-dependent manner: 
initially, the products of LPO and reactive oxygen species (ROS) 
cause activation of Runx2, in response to which RANKL begins 
to be synthesized [82]. Earlier, it was found that mice deficient 
in RANKL and OPG receptors developed clear vascular 
calcification [83]. In other work, OPG has been shown to reduce 
vascular calcification in hypercholesterolemic mice [84]. The 
anti-mineralization effect of OPG is realized through the 
downregulation of the Notch1-RBP-Jkappa metabolic pathway 
and the subsequent reduction of Msx2 and TNSALP mediators 
[85]. OPG inhibits osteoclast differentiation and is a key 
modulator of bone resorption due to its function as a trap 
receptor for the activator of the nuclear factor κB receptor ligand 
(RANKL). It has been investigated that it prevents calcification 
of the media, possibly due to the immunomodulatory effect on 
the low-grade inflammatory process in the vessel wall [86].  
In the study of OPG - / - knockout mice, they revealed 
active bone resorption due to activation of osteoclastic 
differentiation and a massive "leakage" of the bone tissue 
mineral component [87]. 
Fibroblast growth factor 23 (FGF23), Klotho, and 
chronic renal failure (CRF). FGF23 is synthesized in skeletal 
osteocytes in response to hyperphosphatemia on the basis of 
negative feedback [65]. This protein has a molecular weight of 
30 kDa. FGF controls renal phosphate excretion by regulating 
renal sodium, a dependent phosphate co-transporter (NaPi2a and 
NaPi2c). Since hyperphosphatemia is a permanent metabolic 
consequence of CRF, renal proteins are involved in the 
regulation of calcium-phosphorus metabolism, namely, clotho, 
a protein that is expressed mainly in the distal tubules of the 
nephron [88]. It can act as a circulating form, or as a hormone. 
Klotho binds to FGF-23 receptors and opens to different cells 
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the ability to respond to FGF-23 by acting as a cofactor. FGF-23 
and Klotho play an important role in the systemic regulation of 
phosphate homeostasis, reducing their resorption and decreasing 
vitamin D. After vitamin D levels, FGF-23 levels increase, 
reducing renal calcitriol synthesis due to the effect on 
hydroxylase 1α gene. FGF-23 also affects parathyroid hormone 
(PTH), being a negative regulator of its expression. On the 
contrary, PTH stimulates the secretion of FGF-23 from bone 
tissue. The Klotho-FGF-23 axis is assumed to function as 
follows: with the progression of CRF by the help of FGF-23, the 
activity of PTH and 1α - hydroxylase is suppressed, thus 
reducing the level of calcitriol, thus reducing the phosphate 
content [89]. In mice with "knockout" genes FGF-23 and Klotho 
developed a clear calcification of blood vessels and soft tissues. 
Experimental studies have shown that elevation of FGF-23 and 
Klotho protein deficiency can directly induce vascular 
calcification. It has also been established that Klotho can act as 
a circulating inhibitor of vascular calcification [88]. The 
overexpression of Klotho reduces the vulnerability of mice to 
CRF-induced vascular calcification, and conversely, in the 
absence of this protein, the susceptibility of blood vessels to 
pathogenic biomineralization caused by CRF is significantly 
increased [90]. 
Pyrophosphates (PPI). Pyrophosphates inhibit the 
formation of hydroxyapatite crystals. They are formed from 
nucleotides - nucleotide triphosphates - pyrophosphatase, which 
deficiency causes marked calcification of the copper, as well as 
the deficiency of the pyrophosphate transporter - ANK. 
Moreover, the mechanism of pyrophosphate-dependent 
accumulation of calcium in the vascular wall also encompasses 
the inhibition of osteochondrogenic transdifferentiation - the 
same process stimulated by phosphates [91]. Clarifying the 
mechanism of this regulation may pave the way for the creation 
of new pharmacological agents based on bisphosphonates. 
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Receptors advanced glycation end products (RAGE) and 
calgranulins. RAGEs play an important role in the pathogenesis 
of atherosclerosis and the development of concomitant 
pathological mineralization. It has been noted that their 
expression co-localizes with inflammation foci in unstable 
atherosclerotic plaques with microcalcification [92]. In addition, 
compatible localization and increased expression of RAGE with 
vascular SMCs that are subject to osteochondrogenic 
differentiation have been identified [93]. 
RAGE ligands quench soluble forms of these receptors. 
Serum levels of RAGE trap-receptors are inversely associated 
with vascular calcification, confirming the role of these 
receptors in pathological biomineralization. One of these ligands 
is the S100 family proteins: calganulins A, B and C (S100A8, 
S100A9, S100A12) [94]. It has been found that overexpression 
of the RAGE S100A12 ligand in vascular MMCs of mice with 
hyperlipidemia significantly enhances vascular mineralization, 
partially mediated through the activation of LPO [95]. 
Galectin-3 (Gal-3). An important receptor for LPO and 
advanced glycosylation end products is galectin-3. However, the 
role of galectin-3 in the development of atherosclerotic process 
is ambiguous. On the one hand, RAGE stimulation (including 
galectin-3) promotes the development of atherosclerosis through 
their proinflammatory effects [96]. But at the same time, 
galectin-3 contributes to the destruction of LPO products and 
glycosylation and their internalization (endocytosis), which has 
an anti-inflammatory effect [97]. In galectin-3-deficient mice, 
atherogenesis is increased on a diet rich in fat [30]. Galectin-3 
and RAGE have been found to be important in bone formation 
and resorption, modulating skeletal tissue homeostasis [98]. 
Current studies on the role of galectin-3 and RAGE show 
different mechanisms of their action on pathological processes 
of biomineralization. To realize the effects of galectin-3, 
complete acquisition of the osteoblastic phenotype by vascular 
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vascular SMCs is required, causing them to activate β-catenin at 
the level of the nucleus. Runx2 lowers galectin-3, suppressing 
increased osteoclastogenesis, a key factor in osteogenic 
differentiation [2]. 
In addition, RAGE and galectin-3 play a crucial role in 
plaque ulcer and clinical sequelae due to vascular calcification 
and inflammation. In atherosclerotic plaque, RAGE provokes 
and exacerbates inflammation, which leads to the deposition of 
microcalcifications and the occurrence of plaque instability. 
Galectin-3, on the contrary, exhibits anti-inflammatory activity 
only after the calcification process has started, promoting the 
progression of deposition of calcium compounds and causing the 
formation of leaf-like macrocalcification in the vessel walls 
[94]. Despite the opposite effect on inflammation and different 
signaling pathways, RAGE and galectin-3 enhance vascular 
mineralization. 
Due to the formation of macro- (galectin-3) and 
microcalcification (RAGE), the activity of these proteins, 
respectively, leads to the stability or instability of the 
atherosclerotic plaque. General information about the role of 
molecular microenvironment in the development of 
biomineralization is summarized in table 1.1. 
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Table 1.1 – Pro- and anti-mineralization factors in the 
development of biomineral deposits 
Factor Transcription Action 
Tissue nonspecific 
alkaline phosphatase 
TNSALP Promotes mineralization 
Phospho1 
phosphatase 
PHOSPHO1 Promotes mineralization, it is 
a part of the content of MV 
Ectonucleotide 
pyrophosphatase / 
phosphodiesterase 
ENPP1 Produces inorganic 
phosphate, promotes 
mineralization 
Fibroblast Growth 
Factor 23, protein 
Klotho 
FGF23, Klotho Counteract 
hyperphosphatemia and 
mineralization 
Matrix Gla-protein MGP Suppresses mineralization 
Osteoprotegerin OPG Suppresses osteoblast 
differentiation, a modulator 
of bone resorption 
Receptors of nuclear 
activator of nuclear 
factor kappa-B ligand 
RANKL Promotes osteoclastogenesis, 
a promoterization factor 
Fetuin А Fetuin А Calcification inhibitor 
 
Pyrophosphate PPi Suppresses the development 
of biomineralization 
Galectin-3 Gal-3 Inhibits increased 
osteoclastogenesis, promotes 
macrocalcification 
Receptors advanced 
glycation end 
products 
RAGE Proinflammatory factor, 
promotes microcalcification, 
plaque instability 
Calgranulins A, B, C S100A8, 
S100A9, 
S100A12 
They sequester calcium, 
partly contributing to 
calcification 
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1.7 Metabolic features of biomineralization 
The metabolic atmosphere or microenvironment of the 
foci of biomineralization is an important component of the niche 
of biomineralization. It is produced by the structural and 
molecular components of the biomineralization niche, creating a 
specific physico-chemical microenvironment. The metabolic 
microenvironment includes such indicators as the level of 
carbon dioxide and oxygen saturation, acidity, tissue fluid 
pressure, calcium and phosphorus ions content, perfusion, and 
the level of apoptotic processes. 
It is the metabolic component that determines the 
formation of certain crystalline phases and determines the 
directions of biomineralization processes under different organ 
locations. For example, the high level of bicarbonate ions in the 
pancreas and gallbladder causes the formation of biominerals in 
the form of calcite and its related phases (vateritis, dolomite). 
Features of biomineralization in atherosclerosis. For the 
normal performance of its functions, the vascular wall requires 
such properties as elasticity and elongation. Therefore, solid, 
rigid deposits of calcium compounds in the arterial walls have 
important implications for hemocirculation. Obviously, 
increased rigidity of the vessel wall impairs vasomotor activity. 
Pathological biomineralization of blood vessels is widespread, 
affecting approximately 60 % of people over 60 and 80 % of 
people over 80 [65]. 
It is a well-known fact that vascular calcification is an 
unfavorable sign of the development of atherosclerosis and is a 
predictor of cardiovascular pathology and mortality of patients 
[99]. The plaque rupture is a serious destructive consequence of 
atherosclerosis [65]. Biomechanical analysis shows that rigid 
(dense) inclusions - calcifications in the wall of the arteries 
increase the pressure on the stressed surface of the vessel in the 
areas of direct influence of the negative factor, thus increasing 
the risk of rupture [99]. Further studies of this problem show that 
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the likelihood of such a complication increases significantly in 
the case of close localization of two microcalcification deposits 
[25]. In the case of localization in the heart valves, the 
consequences may be more severe as there is a violation of the 
hemodynamic flow. For example, in the case of calcified aortic 
stenosis, backflow from the left ventricle is blocked. In general, 
the biomineralization of blood vessels and heart valves leads to 
such adverse clinical effects as systolic hypertension, left 
ventricular hypertrophy, coronary ischemia, congestive heart 
failure, atherosclerotic plaque rupture, thrombosis, myocardial 
infarction. 
The cardiovascular system is characterized by the 
formation of biomineral compounds of calcium phosphate salts 
in different ratios between Ca and R. The general information on 
this subject is summarized in table 1.2. 
Apoptosis and biomineralization in soft tissues. In the 
foci of chronic inflammation, cellular damage and death, 
including DNA damage, autophagy, and apoptosis, are 
widespread. In the process of apoptosis, vascular SMCs release 
MV and apoptotic bodies capable of concentrating calcium and 
forming calcium phosphate crystals [100]. Thus, factors 
contributing to cell death also enhance biomineralization 
processes. For example, prelamin A blocks DNA repair and 
promotes osteoblastic differentiation and mineralization of 
vascular cells [101]. 
  
31 
 
Table 1.2 – The main compounds of calcium phosphate, 
which involved in the processes of pathological 
biomineralization of the cardiovascular system 
Name JCPDS Formula 
and Number (Joint 
Committee on 
Powder Diffraction 
Standards) 
Ca / P 
ratio, 
at % 
Density, 
g / cm-3 
Monocalcium phosphate 
monohydrate (MCPM) 
Ca(H2PO4)2 H2O  
9-0347 
0.5 2.23 
Monocalcium phosphate 
anhydrous (MCPA)  
Ca(H2PO4)2  
9-0390 
0.5 2.58 
Dicalcium phosphate 
dihydrate 
(mineral - brushite)* 
(DCPD)  
CaHPO4 2H2O  
9-0077 
1.0 2.32 
Dicalcium phosphate 
anhydrous 
(mineral - monetite)* 
(DCPA)  
CaHPO4  
9-0080 
1.0 2.89 
Octacalcium phosphate  
(OCP)  
Ca8H2(PO4)6 5H2O 
26-1056 
1.33 2.61 
-tricalcium phosphate 
(-TCP, Mg -TCMP) 
-Ca3PO4, -
(Ca,Mg)3PO4  
9-0169 
1.5 308 
Hydroxyapatite (HA) Ca10(PO4)6(OH)2  
76-0694 або 9-0432 
1.67 3.16 
* Natural minerals of brushite and monetite do not fully correspond 
to the idealized DCPD and DCPA orthophosphates, respectively 
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2 DISEASES ASSOCIATED 
WITH BIOMINERALIZATION: 
PATHOMORPHOLOGICAL FEATURES 
Diseases associated with biomineralization can be 
defined as diseases in where the formation of biomineral 
deposits, which have a significant impact on their course and 
prognosis of a particular pathology. Today, many common 
human diseases are known, which are associated with the 
formation of biominerals of a predominantly calcium-phosphate 
nature [102]. Among these nosologies, atherocalcinosis of 
vessels and heart valves, chole-, nephro-, sialo-, pancreatic-, 
prostatolithiasis, calcification in cancer of the thyroid gland, 
uterus and other localizations are the most common [5].  
An epidemiological study was conducted on diseases 
associated with biomineralization, which contained samples of 
PBM studied in this work and are most common in the Ukrainian 
population: coronary heart disease (CHD), cholelithiasis (ChL), 
prostate cancer (PC) and thyroid cancer (TC). 
The causes that lead to an increase in the prevalence of 
diseases associated with biomineralization are extremely diverse 
and diverse: environmental, socio-economic, climatic, 
metabolic disorders. 
 
2.1 Pathological biomineralization in the cardiovascular 
system 
The socio-economic significance of CHD is confirmed 
by the fact that it accounts for 2/3 of deaths from cardiovascular 
disease [103]. The presence of biomineralization in the 
cardiovascular system is an important predictor of morbidity and 
mortality. Thus, the deposition of calcium deposits in soft 
cardiovascular tissues disturbs the biomechanical functions of 
these tissues and leads to complications such as heart damage, 
myocardial infarction, and stroke [104], so their study is of great 
interest. 
33 
 
Comparison of the prevalence of coronary heart disease 
in the population of Sumy region and Ukraine shows a 
predominance of indicators of this pathology at the national level 
during the period 2012-2016 (Fig. 2.1). But the average annual 
growth rate of CHD in the Sumy region was 101.86  % as 
opposed to the Ukrainian average - 95.9 %. The average 
prevalence of coronary heart disease each year has increased by 
1.86 % in the Sumy region, while the average Ukrainian index 
is negative (-4.10 %). 
 
Figure 2.1 – Comparison of CHD prevalence among the 
population of Sumy region and Ukraine during 2012-2016 
 
During the observation period it was found that the 
incidence of coronary heart disease in the Sumy region is lower 
than the average in Ukraine (Fig. 2.2). At the same time, the 
following trends are noted: the incidence of coronary heart 
disease in Ukraine is decreasing, and in the Sumy region its slow 
growth is observed. On average, every year the incidence of 
coronary heart disease has increased by 0.02 % in the Sumy 
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region, while the average Ukrainian indicator was negative           
(-8.45 %). 
 
Figure 2.2 – Comparison of CHD incidence among the 
population of Sumy region and Ukraine during 2012-2016 
 
Structural changes in the demographic situation in the 
countries of Europe and Ukraine towards the increasing 
population of older age groups leads to an increase in 
degenerative-metabolic diseases. In this regard, the prevalence 
of aortic atherosclerotic lesions and valvular structures of the 
heart is increased, which significantly impairs the quality of life 
and prognosis for patients [105]. For example, the prevalence of 
heart valve lesions of different origins is 20-30 % of patients 
over the age of 65 [106] and reaches 48-57 % in eighty-year-old 
patients [2, 107, 108]. 
The biomechanical properties of histological tissues 
depend on the microarchitecture of the extracellular matrix 
(ECM) [109]. Calcification disrupts the soft tissue 
histoarchitectonics by depositing solid mineral deposits [110]. 
Loss of biomechanical stability of the cardiovascular system 
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leads to acute or chronic adverse complications, such as 
violation of the integrity and deformation of the walls of the 
vessels and heart, valve apparatus, heart attacks. Two types of 
cardiovascular biomineralization are of paramount importance 
for human health: micro- and macro-calcification [2]. 
It is widely accepted that microcalcification, or so-called 
spotty calcification, associated with increased cardiovascular 
mortality [111]. The biomechanical aspects of 
microcalcification are discussed in several recent works, which 
discuss the pressure distribution in the atherosclerotic plaque 
and the mechanism of its rupture by mineral deposit [92]. 
Diffuse calcifications, which form solid fragments of more than 
5 mm, usually located in the form of sheets (sheet-like 
calcification), are defined as a manifestation of 
macrocalcification [2]. In contrast to spot calcification, 
macrocalcification stabilizes the atherosclerotic plaque and 
serves as a barrier to inflammation [111]. 
Damage to the aortic valve (AV) with calcification of the 
valve apparatus is the most common heart valve disease in 
Europe and the United States, especially in older people [110]. 
Thus, in developed countries, about 50 000 operations of cardiac 
valve replacement are performed every year due to this 
pathology [112]. 
This has led to an increase in the number of elderly 
patients with non-rheumatic valve involvement: they are more 
likely to have ischemic heart disease, congestive heart failure, 
undergo surgery for myocardial revascularization, type II 
diabetes, and chronic kidney disease [109]. According to the 
Euro-Heart Survey on Vascular Heart Disease, degenerative 
etiology dominates for aortic stenosis (81.9 %), predominates 
for mitral (61.3 %) and aortic (50.3 %) insufficiency. Only for 
mitral stenosis, rheumatological factors remain the main 
etiological factors (85.4 %) [109]. The most common pathology 
of acquired heart defects is non-rheumatic aortic stenosis, which 
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is also called calcified aortic stenosis (CAS), since in its 
pathogenesis the main role belongs to the process of 
biomineralization of the shutters  and valve rings [111]. In 
addition, the mean age of patients with CAS is higher than that 
of other valve pathology. Thus, the demographic-induced 
increase in degenerative-metabolic diseases of the human body 
leads to an increase in the proportion of calcification of the heart 
valves. 
The degree of mineralization of the aortic valve is 
estimated by echocardiography:  
І degree of calcification corresponds to the focal deposits 
of calcium compounds in the cusps and commissures;  
II degree – rough calcification of cusps and AV 
commissures, which does not cover the areas of attachment of 
cusps;  
ІІІ degree is the massive deposition of calcifications with 
the transition to the fibrous valve ring, the aorta and the outlet of 
the left ventricle, the anterior cusp of the mitral valve [113].  
As you can see, in the case of severe atherosclerotic 
lesions, the combination of different "lodges" of atherosclerosis 
is combined into one pathological focus. 
According to the classical definition of WHO, the 
concept of atherosclerosis includes "a variable combination of 
damage to the inner lining of the arteries, which consists of 
deposits of lipids, hydrocarbons, blood components, connective 
tissue and minerals" [92, 103]. The aorta is the most common 
localization of the atherosclerotic process. The general 
mechanism that leads to the development of biomineralization 
in blood vessels is being actively researched but is not yet 
completely understood. An atherosclerotic lesion with the 
presence of calcifications in classical pathology is considered a 
manifestation of complicated disease. Still, microcalcifications 
begin to emerge at the lipid stage [99]. 
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In the developed countries of the European Community 
and North America, the modified Virmani R. (2003) 
morphological classification is used, which is a modification of 
the AHA (American Heart Association) classification [114]. All 
morphological changes in the walls of the vessels are divided 
into groups of early changes, unstable and stable disorders. Early 
changes include adaptive intimal thickening (AIT), intimal 
xanthoma (IX), pathological intimal thickening (PIT), and early 
fiber atheroma (EFA). Unstable (prevulnerable) conditions are 
considered late fibroatheroma (LFA), thin fiberoatheroma 
(TCFA), ruptured plaque (PR) and complete rupture of plaque 
(HR). A stabilized atherosclerotic condition is defined as fibrous 
calcified plaque (FCP). Some authors believe that the first 
calcium deposits in atherosclerotic lesions appear at the stage of 
late fiberoatheroma [92]. 
Obviously, the deposition of calcium phosphate minerals 
in the aortic wall, affected by the atherosclerotic process, takes 
some time from the moment of the onset of the underlying 
disease. In our study, this is confirmed by comparing the average 
age of patients in the aortic control group and the aortic group 
with biomineralization available, corresponding to 68.43 ± 1.32 
(biomineral) and 51.8 ± 2.56 (control) (p < 0.05) years 
respectively [115]. 
Macroscopic examination of the aortic tissue with 
biomineralization revealed that, against the background of 
atherosclerotic lesions, calcium compounds were deposited in 
the area of the inner lining of the vessel. In cases of expressive 
stages of development of the pathological process, calcification 
also extended to the middle sheath. Histological examination 
showed a typical list of pathological changes in the aortic wall: 
focal deposition of lipids with the formation of cholesterol cysts, 
sclerotic changes with thickening of collagen and elastic fibers, 
edema, deposition of calcium deposits of different morphology 
and size, chronic inflammatory infiltration. 
38 
 
An element such as inflammation can occur as a reaction 
to atheromatous detritus and biomineralization. The significance 
of chronic inflammation in the development of pathological 
biomineralization in recent years has been given an extremely 
important place. It is believed that the predominance of pro-
inflammatory stimuli in the development of atherosclerotic 
process leads to the development of prognostically unfavorable 
microcalcification, and in the case of the predominance of anti-
inflammatory stimuli occurs macrocalcification, which 
contributes to the stabilization of atherosclerotic plaque [111]. 
A standardized set of immunohistochemical markers: 
MPO, CD68, S100A8, S100A9, Caspase3 and OPN were used 
for the immunohistochemical study of pathological 
biomineralization processes under different localizations in the 
soft tissues of the human body. The results of the 
immunohistochemical study were evaluated by counting stained 
cells in a field of view with a diameter of 1 000 μm in the 
environment of the morphometric programs "Pannoramic 
Viewer 1.15.4" and "SEO Scan Lab 2.0". 
One of the central cores of our work was the study and 
clarification of the role of calcium-binding proteins of the 
calgranulіns A (S100A8) and B (S100A9) and the calprotectin 
complex S100A8 / S100A9 in pathological biomineralization 
processes (Fig. 5). Calgranulins A and B are produced and 
secreted by a wide range of cells, but most of them contain 
neutrophils (up to 40 % of cytoplasmic proteins) and cells of the 
macrophage row (up to 10-15 % of cytoplasmic proteins) [116]. 
Therefore, the neutrophil markers of myeloperoxidase (MPO) 
and the CD68 macrophage differentiation cluster were used to 
identify the major "suppliers" of S100A8, S100A9 proteins and 
their heterodimeric complex S100A8 / A9. CD68 expression 
also occurs in some endothelial cells and fibroblasts, but they 
can be easily distinguished by specific cell morphology and 
localization. 
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Assessment of the level of elimination of cells in the 
pathological cell was performed using a marker of apoptosis 
caspase 3 (Casp3). The advantage of using Casp3 is that this 
marker directly indicates irreversible apoptotic cell changes, 
which takes precedence over other markers (eg, bax). 
 
Figure 2.3 – Scheme of the role of calgranulins A and B in the 
development of pathological biomineralization of soft tissues 
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The death of a large number of cells leads to the creation 
of conditions for the development of biomineralization 
processes: calcium ions and phosphate groups from nucleic 
acids and ATP are released from the calcium depots of the dead 
cells, and a connective tissue matrix can be used as a matrix for 
deposition of calcium biomineral deposits. In some sample 
groups (aorta, aortic valve), monoclonal antibodies against type 
I collagen were used to detect it, since this protein is a natural 
matrix for bone mineralization. Immunohistochemical 
determination of OPN protein was used to evaluate the 
interaction of soft tissues and biominerals. This protein is known 
to be multifunctional with cytokine activity, has 
proinflammatory properties, and is secreted by a number of 
inflammatory infiltrate cells and soft tissues in response to the 
occurrence of calcium phosphate biominerals [117]. It is also 
known that it is able to interact with hydroxyapatite, inhibiting 
the growth of its crystallized forms [118]. 
 
Figure 2.4 – Results of immunohistochemical study of aortic 
tissue. The average number of immuno-positive cells in the 
field of view. * - statistically significant values (p < 0.05) 
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Therefore, in comparing the results of 
immunohistochemical study of protein expression in aortic 
tissue I and II groups, a significant difference was found between 
the results of groups for markers of CD68+ cells of the 
macrophage row (p < 0.001), components of the calprotectin 
complex - calgranulin A (S100A8) – p < 0.01) and B S100A9 - 
(p < 0.001), the Casp3 apoptosis marker (p < 0.05) and the OPN 
biomineralization marker (p < 0.001). For the MPO neutrophil 
marker, no significant difference between the parameters of the 
studied groups was detected (p> 0.05) (Fig. 2.4). 
The difference between the results of the 
immunohistochemical study of the expression of CD68, 
S100A8, S100A9, Casp3 and OPN in the 1st and 2nd groups of 
aortic specimens indicates their role in the processes of 
biomineral deposits formation under the conditions of the 
atherosclerotic process. Obviously, the "calgranulin" pressure 
on the cells of the aortic wall and especially its inner layer, is 
carried out by cells of the macrophage row, which are high in 
saturation and can be noticed without any special studies already 
at the stage of analysis of microslides, stained with hematoxylin. 
The amount of calgranulin B was estimated to be higher, but the 
level of calgranulin A was also higher in mineralized tissues. 
The formation of the heterodimer calprotectin complex is 
confirmed by immunofluorescence study with the simultaneous 
use of two markers using Alexa 488 and Alexa 555 tags 
(Fig. 2.5). 
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Figure 2.5 – Immunofluorescence study of S100A8 and 
S100A9 expression in group I aortic tissue co-localized as 
calprotectin. Blue is dapi, blue-green - Alexa 488 (S100A8), 
yellow-green - Alexa 555 (S100A9), orange is calprotectin 
S100A8 / A9. Magnification x200 
 
In the study of the presence of calprotectin in the tissues 
of the aorta using immunofluorescence antibodies, it is 
noticeable that in mineralized samples significantly more 
calprotectin complexes (in the photo is shown in orange) are 
formed (Fig. 2.5, 2.6). 
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Figure 2.6 – Immunofluorescence study of S100A8 and 
S100A9 expression in group II aortic tissue co-localized as 
calprotectin at the border of the atheromatous plaque. Blue is 
dapi, blue-green - Alexa 488 (S100A8), yellow-green - Alexa 
555 (S100A9), orange is calprotectin S100A8 / A9. 
Magnification x100 
 
Immunohistochemical study of the mineralized aortas of 
group I revealed high expression of the proapoptotic marker 
Casp3 in the areas of atherosclerotic plaque development, 
around small vessels and biomineral deposits, which was 
consistent with the data obtained on calprotectin activity. The 
expected result was the detection of OPN protein around 
atherosclerotic plaques and biomineral deposits, which were 
accompanied by inflammatory infiltration. 
The results obtained using applied materials science 
methods for the study of group I aortic specimens clearly 
indicate the predominance of the structural defective carbonate-
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containing apatite B-type among the biominerals (CO3
2– ions 
replace PO4
3–). These results were obtained by SEM with 
microanalysis, IR spectroscopy, TEM with ED, and X-ray 
spectroscopy. 
The close interaction of the mineral and organic 
components of the wall of the atherosclerotic aorta leads to the 
formation of a structure by type of biocomposite material [119]. 
We found an interesting difference in the morphology of crystals 
of micro- and macrocalcifications (Fig. 2.7). Microcalcifications 
had sharp edges, radiant or irregular in shape, which may 
contribute to the inflammation and destruction of the soft tissue 
of the atherosclerotic plaque and its rupture. On the other hand, 
the macrocalcifications had a regular shape with relatively 
smooth edges and uniform thickness, possibly due to their 
formation on the smooth surface of the biological tissue (for 
example, connective tissue coating of atherosclerotic plaque). 
This process took place by a matrix-directed growth mechanism 
on an organic substrate under favorable conditions in the 
absence of inflammation and other stress effects. 
 
 
 
Figure 2.7 – Scheme of placement of micro- and 
macrocalcifications in the walls of the aorta 
 
The origin and development of pathological 
biomineralization in the heart valves affected by the 
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atherosclerotic process requires some time from the onset of the 
underlying disease. In our study, this is confirmed by the mean 
age of the patients, which corresponds to 68.91 ± 1.49 years. 
Macroscopic examination of the aortic heart valves 
showed that at atherosclerotic lesions, biomineral deposits were 
localized in the cusps or in the fibrous ring. Histological 
examination revealed a typical list of pathological changes in the 
tissues of the heart valves: thickening of the fibrous layer and 
elastic fibers, focal deposition of lipids, myxomatous changes, 
phenomena of edema, deposition of calcium deposits of various 
morphologies and sizes, chronic inflammatory infiltration. 
Similar pathohistological signs accompanied the atherosclerotic 
process. They are often associated with secondary inflammation 
in response to atheromatous detritus and pathological 
biomineralization. In the latter case, a typical "circulus vitious" 
was formed: under the influence of pro-inflammatory stimuli, 
deposits of calcium in the form of grains, splinters, or granules 
were deposited, which irritate the surrounding tissues, causing 
inflammation [2, 94]. 
Pathological biomineralization is commonly thought to 
begin with the aortic valve and then extend to the mitral valve, 
left ventricle, and interventricular septum. Biomineralization 
dramatically alters the elasticity and elongation of the tissue of 
the valve apparatus, contributing to the development of its 
insufficiency, left ventricular hypertrophy and reduced cardiac 
muscle contractility in the future [65]. 
It is known that cardiovascular calcification is an 
unfavorable sign of the development of atherosclerosis and is a 
predictor of cardiovascular pathology and mortality of patients 
[99]. Particularly dangerous may be the destruction of an 
atherosclerotic plaque located on the valve petals or in the area 
of communication with the muscles [65]. There is an interesting 
opinion that microcalcifications have a higher damaging 
potential for tissue rupture [99]. A particularly dangerous 
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situation arises in the case of close localization of two 
microcalcification deposits [25]. Conversely, the formation of 
leaf-like calcifications in the cardiovascular system 
("macrocalcification") stabilizes the atherosclerotic plaque and 
may act as a barrier to inflammation [2]. 
Current studies show the important role of Toll-like 
receptors 2 (TLR2) and TLR4 in the development of calcified 
aortal valve (CAV). Thus, expression of TLR2 and TLR4 causes 
osteogenic phenotypic changes in AV interstitial cells [121]. 
Involvement of (TLR2) and TLR4 in biomineralization 
processes draws attention to the agonist of these receptors, the 
calprotectin complex [S100A8 / S100A9], consisting of 
calgranulin A (S100A8) and calgranulin B (S100A9) [122]. 
In recent years, osteopontin, which is a proinflammatory 
multifunctional cytokine and a promising marker of the presence 
and degree of AV mineralization, plays an important role [123]. 
The deposition of calcium compounds in CAV occurred 
both in the form of coarse deposits and in the form of fine grains, 
crumbs, which encrusted connective tissue fibers. The affected 
valves were characterized by sclerosis and tissue hyalinosis, 
focal lipid deposition, edema, myxomatous changes, thickening 
of elastic and collagen fibers. This was especially the case for 
type I collagen, which has the highest tendency for calcification 
[124]. Important pathohistological changes in CAV were 
inflammatory mixed-cell infiltration by cells of the macrophage 
origin (histiocytes, macrophages - CD68-positive cells and 
neutrophils (MPO-positive cells). 
An immunohistochemical study of the expression of 
calgranulin A (S100A8) in CAV tissue showed focal expression 
in inflammatory infiltrate cells, but no significant extracellular 
expression was detected. A study of the distribution of 
calgranulin B (S100A9) showed its pronounced expression in 
the tissues of calcified aortic valves both extracellularly and 
intracellularly in most resident valve cells and circulating 
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inflammatory cells. In the IHC - the study of CAV tissue with 
fluorescent antibodies to S100A8 (Alexa 488, red) and S100A9 
(Alexa 555, yellow), the co-localization of these molecules in 
the calprotectin complex stained the cytoplasm of S100A8 / 
S100A9 cells in orange (Fig. 2.8). 
 
 
Figure 2.8 – Immunofluorescence study of S100A8 and 
S100A9 protein expression in tissue of group I aortic valves 
co-localized as calprotectin. Blue is dapi, blue-green - Alexa 
488 (S100A8), yellow-green - Alexa 555 (S100A9), orange is 
calprotectin S100A8 / A9. Magnification x200 
 
 
A study of apoptotic activity in CAV tissues, conducted 
by studying the level of expression of the marker of apoptosis 
Casp 3, showed a moderate expression of it in the cells of the 
valve petals. 
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OPN expression was strongly expressed in most CAV 
cells and extracellular space. Intense deposition of this protein 
in calcification sites was also noted. 
Immunohistochemical study of AV samples of control 
groups showed the following results. During identification of 
CD68+ cells in AV tissue, their number was found to be 
significantly lower than that of the control group (p < 0.05). On 
the other hand, CAV also contained a significantly higher 
number of MPO+ cells (p < 0.001). 
In the study of the expression of the S100A8/S100A9 
heterodimer using fluorescent antibodies, significantly fewer 
cases of co-localization of these proteins as a single complex 
revealed than in the CAV group (Fig. 2.9). However, the 
expression level of S100A8 in the tissues of the control group 
was expressed moderately, mainly in the interstitial cells and 
was not significantly different from the group of samples of 
biomineralized valves (p> 0.05). Control groups showed 
markedly lower levels of S100A9 expression both in the cellular 
component of the tissue and in the extracellular space (p < 0.01). 
This also concerned the expression of the Casp3 
apoptosis marker (p < 0.05) and the OPN mineralization marker 
(p < 0.001), the levels of which were significantly lower in the 
control group. 
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Figure 2.9 – Immunofluorescence study of S100A8 and 
S100A9 expression in group II aortic tissue co-localized as 
calprotectin at the border of the atheromatous plaque. Blue is 
dapi, blue-green - Alexa 488 (S100A8), yellow-green - Alexa 
555 (S100A9), orange is calprotectin S100A8/A9. 
Magnification x100 
 
Therefore, in comparison with the results of 
immunohistochemical study of samples of aortic tissue in 
control group there is a noticeable difference in the expression 
of calprotectin complex: the content of its smaller subunit - 
calgranulin A was not statistically different from the control 
group of AV’s. It is also necessary to note the difference in the 
authenticity level (p = 0.42) between CD68+ cells in the groups 
studied. It can illustrate different conditions of development of 
pathological process at localization in the aorta and aortic 
valves: different expressiveness of inflammation, different 
degree of involvement in the atherosclerotic process (influence 
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on infiltrate composition), different local conditions (level of 
blood pressure, structural features). These causes affect the 
composition of donor cells of calgranulins. They ultimately 
cause differences in the features of the mechanism of 
development of pathological biomineralization. Obviously, this 
led to a predominance of the effect of calgranulin B in the tissue 
of mineralized AV. This necessitated further verification of the 
difference in the content of the key protein S100A9 in 
mineralized and control AVs. It was isolated from the valve 
tissue and quantified using dot-blot analysis. 
The results of immuno-dot studies of S100A9 protein in 
AV tissue also showed a significant difference in its content in 
mineralized and control samples (p <0.05). 
The difference between the results of 
immunohistochemical study of MPO, CD68, S100A9, Casp3 
and OPN expression in the 1st and 2nd groups of AV samples 
indicates their role in the processes of biomineral deposit 
formation. 
Pathological biomineralization of heart valves leads to 
deep morphofunctional restructuring of all components of their 
structures. The quantitative and qualitative composition of the 
valve interstitial cells (VICs) and the fibrillar component 
(collagen and elastin) changes and due to that adversely affected 
endothelial cells (ECs) that cover the surface and interact closely 
with the interstitial valve cells, ensuring the integrity of the valve 
tissue [58]. Necessary conditions for the destruction of EC are 
created in atherosclerosis: infiltration by lipids, plaque and 
detritus formation, infiltration by circulating inflammatory cells 
(CIC) [124]. The CPCs (macrophages, lymphocytes, 
neutrophils, plasmocytes) are known to actively secrete 
calgranulins A and B, which make up the calprotectin complex 
(heterodimer) S100A8 / S100A9. It has cytotoxic effects at high 
concentrations [125]. 
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In the study, the presence of calprotectin in AV tissue 
was confirmed by the co-localization of these proteins with their 
simultaneous staining with fluorescent antibodies against 
S100A8 and S100A9. A high concentration of S100A9, the 
active component of calprotectin S100A8 / S100A9, in tissues 
CAV was also detected using a dot-blot. 
In conditions of inflammation, such influence of 
S100A8/S100A9 triggers apoptosis processes in EC and VICs 
(involving the mitochondrial pathway and caspase-3 and 
caspase-9), and necrosis may also occur [125, 126]. In our study, 
this was reflected in high Caspase 3 expression in the AV sample 
group with biomineralization compared to the control group 
(p < 0.01). Morphologically, this was manifested by 
desquamation and detachment of the endothelium, deep damage 
to the valve petals. Therefore, calprotectin-dependent EC 
damage may be a critical element in the morphogenesis of 
vascular biomineralization in chronic inflammation and 
atherosclerosis. 
Much of the effects of S100A8 / S100A9 are realized 
through Toll-like receptors, which are present in EC, fibroblasts, 
and inflammatory cells [127, 128]. Activation of glycolysis end-
product receptors (RAGE) and TLR4 can accelerate vascular 
calcification both in vitro and in vivo [129]. 
Several recent studies have been devoted to the study of 
OPN expression in cardiac valves [130, 131]. The results of our 
study show an increased expression of OPN in the tissue of 
mineralized heart valves - both in the extracellular environment 
and in the valve cells (interstitial and circulating) compared with 
the control group. Also, a significant amount of OPN was found 
in biomineral deposits. This is consistent with numerous 
publications that report that OPN binds to the surface of 
hydroxyapatite crystals, blocking its growth [118]. 
Osteopontin and calgranulin B are actually synthesized 
and secreted by the same cells, the leading role among which are 
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neutrophils and macrophages. In IHC study CD68+ cells were 
found to be superior (in the authenticity level p = 0.42) in 
mineralized AV tissues (p <0.05). The number of neutrophils in 
CAV also significantly exceeded the corresponding indicator of 
the control group. In fact, this means that calgranulin B-
cytotoxicity and AV tissue damage are realized through 
neutrophils and cells of macrophage row. As calgranulins A and 
B make up about 40 % of the cytoplasmic proteins of 
neutrophils, this is logically consistent with the high 
concentration of calgranulin B in CAV [126] (Fig. 2.10). 
 
 
Figure 2.10 – Results of the immunohistochemical study of the 
tissue of the CAV cusps. * – statistically significant values 
(p < 0.05) 
 
The inflammatory process in the AK leads to changes in 
the extracellular matrix of their tissues, disturbing the balance 
between local pro- and anti-calcium mechanisms. This creates 
favorable conditions for the deposition of minerals. For 
example, type I collagen in tissue CAV maintains osteogenic 
differentiation of SMCs, the number of which increases under 
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pathological conditions in valves from 5 % to 30 % [120]. Valve 
interstitial cells (VICs) that interact with collagen type I remain 
in a "calm" state for a long time. But with the appearance of 
fibrin, which inevitably occurs during the development of 
atherosclerotic plaque, they demonstrate a myofibroblastic 
phenotype and rapidly form calcium aggregates [120]. 
Therefore, under the influence of damaging factors, the 
desquamation of the integumentary endothelium and the 
denudation of the connective tissue matrix emerge. Cell death 
promotes the release of a large amount of inorganic phosphate 
and calcium. Thus, a considerable amount of building material 
and the presence of connective tissue matrix (type I collagen) 
creates conditions for the development of pathological 
biomineralization in human aortic valves, the mechanism of 
development of which can be demonstrated as follows 
(Fig. 2.11). 
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Figure 2.11 – A potential mechanism for the involvement of 
calgranulin B in the development of calcification AV 
 
2.2 Pathological biomineralization in thyroid cancer 
The share of thyroid cancer in recent decades has been 
steadily increasing worldwide. Thus, according to the 
worldwide study of the incidence and mortality of malignant 
tumors GLOBOSCAN in 2012 revealed 298 thousand new cases 
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of thyroid cancer. The highest incidence of thyroid cancer is 
observed in the United States (20 per 100 000 population among 
women and 6.3 per 100 000 among men). For Ukraine, the 
incidence of thyroid cancer has increased by 6-7 % annually 
between 1989 and 2013 [132]. the region has one of the highest 
rates of cancer incidence in the country, which in the last 5 years 
has fluctuated within 10.3 - 15.1 cases per 100 thousand 
population [41]. 
The decisive influence on the clinical behavior of 
malignant tumors of any localization and the overall survival 
rate of patients exerts a histological phenotype of the neoplasm, 
so the question of accurate diagnosis is extremely important. In 
recent years, a number of scientific papers have underlined the 
significant diagnostic and prognostic role of pathological 
biomineralization in malignant thyroid tumors  (MTT) 
morphogenesis [133-135]. 
An important and poorly researched manifestation of 
pathological biomineralization in MTT tissue is vascular wall 
damage or vascular calcification (VC). This phenomenon is 
most often found as a manifestation of pathological 
biomineralization of the thyroid gland, rarely - follicular cancer 
of the thyroid gland. 
Because the PTC is the most common thyroid tumor, 
occupying up to ¾ of the volume in the thyroid disease structure 
[38, 41], therefore, an extensive immunohistochemical study of 
vascular calcification of the thyroid gland was performed on a 
group of papillary thyroid carcinoma specimens. 
The study of VC problems also covered the calcification 
of intravascular tumor emboli, which is a substrate for the 
formation of psammoma bodies and an integral part of 
pathological biomineralization of vessels [40]. 
Macroscopic examination of tissue specimens of 
follicular cancer of the thyroid gland showed the tumor as nodes, 
which often had a thick capsule in their composition. Biomineral 
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formations of follicular cancer of the thyroid gland are more 
often found during the dissection of tumor tissue than during 
visual examination of a malignant neoplasm. The incision was 
difficult and was accompanied by a characteristic crunch. The 
follicular cancer of the thyroid gland had a yellowish-grey color, 
relatively soft in consistency (Fig. 2.12A). Deposits of 
biominerals are most often localized in the tumor parenchyma 
and capsule nodes. They appeared in the form of solid 
formations of white color irregular shape, mainly had small sizes 
(up to 1.0 cm). 
 
Figure 2.12 – Macroscopic examination of thyroid cancer. A. 
Macrophotography of follicular thyroid cancer. A thick solid 
white capsule is noticeable in the section. B. Macropreparation 
of papillary thyroid cancer with isolated lymph nodes and 
subcutaneous fat. The incision shows the tumor as a thick 
whitish tissue 
 
Macroscopic examination of the PTC in most cases 
revealed a tumor of the nodular structure, with the presence of 
villi. In some cases, PTC was represented by cystic formation 
with bloody content and smooth papillary growths. The presence 
of a capsule for PTC was not a permanent feature. In general, 
the tumor tissue was white-grey, sometimes pinkish-yellow in 
color, with a dense texture (Fig. 2.12 B). The size of the tumor 
nodes varied from 0.8 to 4.0 cm. PBM of the PTC was 
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manifested as small very solid deposits of grey-white tissue, 
which were localized in the tumor parenchyma. In some cases, 
biomineralized formations were found in the 
pathomorphological examination of the lymph nodes. 
In the course of histological examination of the follicular 
cancer of the thyroid gland, it was revealed that the tumors 
consisted of small follicles that were partially filled with colloids 
and formed by cells with varying degrees of atypism. Follicular 
cancer of the thyroid gland was characterized by invasive tumor 
growth into the surrounding tissue or capsule. Individual tumors 
consisted of solid masses of polygonal or spindle-shaped cells, 
with trabecular structure. Polymorphism, pathological mitoses 
were characteristic of the tumor cells of the follicular cancer of 
the thyroid gland, but such phenomena as nuclear grooves, 
accumulation of vitreous nuclei ("Orphan Ann's eyes", "egg 
basket") and psammoma bodies were not characteristic. The 
accumulation of condensed, bright pink colloid color in the 
follicles of adjacent healthy tissue was revealed by the staining 
of tumor tissue by PAS reaction (Fig. 2.13 B). 
 
Figure 2.13 – Histological examination of the follicular cancer 
of the thyroid gland. A. Invasive growth of follicular cancer of 
the thyroid gland into the surrounding tissue. Hematoxylin-
eosin staining. x100. B. Accumulation of PAS-positive colloid 
in thyroid tissues adjacent to the tumor. PAS reaction. 
Magnification x100 
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The processes of pathological biomineralization in the 
tissue of follicular cancer of the thyroid gland have damaged 
both the elements of the parenchyma (follicular epithelium, 
colloid) and the stromal component (capsule, interfollicular and 
interstitial layers). There was also a combination of 
biomineralization of parenchymatous and stromal elements with 
the formation of large margins of mineralized tissue, which were 
easily detected during the preparation of the material for 
histological examination (Fig. 2.14). 
 
Figure 2.14 – Histological examination of the follicular cancer 
of the thyroid gland. A. Combination of biomineralization of 
stromal and parenchymatous tumor structures. B. Pathological 
biomineralization of venous and arterial vessels of the 
follicular cancer of the thyroid gland. Hematoxylin-eosin 
staining. Magnification in x100 and x400 respectively 
 
It should also be noted that the phenomena of vascular 
calcification developed in vessels of medium and small calibre, 
mainly venous (Fig. 2.14 B, Fig. 2.15 A, B). Sometimes 
monolithic crystals in the form of boulders or plates were formed 
in the walls of vessels. The deposition of biominerals occurred 
in the inner and middle layers of the vessel walls, whereby 
predominantly partial calcification of the cross-section of the 
vessel in the limited length section was revealed. For small 
vessels (by type of capillaries, venules or arterioles), 
59 
 
characteristic total mineralization of the entire wall was 
observed. 
 
 
Figure 2.15 – Histological examination of vascular 
calcification of the follicular cancer of the thyroid gland. A. 
Biomineralization of vessel walls and stromal calcification. 
Alizarin red staining, mag. x100; B. Deposition of 
calcifications in the capsule and the walls of its vessels. 
Alizarin red staining, magnification x400 
 
Histological examination of the PTC showed that the 
group of test specimens of thyroid neoplasms consisted of 21 
cases of the classic version of the PTC (CvPTC) and 3 cases of 
the diffuse-sclerotic variant of the PTC (DSvPTC). In the 
histologic examination, CvPTC was a tumor of the papillary or 
cystic structure with the papillae that were branching. The 
papillae were put by one or more layers of epithelial tumor cells 
with signs of atypia. Highly differentiated tumors with 
monomorphic cubic epithelium were more common. There was 
a different degree of loss of differentiation with the development 
of cell polymorphism. The papillary outgrowths had a fibrotic 
base with a large number of dilated small vessels, small 
hemorrhages (Fig. 2.16 A). In addition to the vascular 
component, the connective tissue base of the papillae contained 
a marked inflammatory infiltration of mixed-cellular nature. A 
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high level of desquamation of the papilla epithelium was 
observed (Fig. 2.16 B). Pathological biomineralization, which 
accompanied CvPTC, was characterized by the presence of PBs, 
which were most often localized in the fibrous basis of the 
papillae (Fig. 2.17 A, B). 
 
Figure 2.16 – Histological examination of the PTC. A. The 
classic version of PTC. B. Desquamation of the tumor 
epithelium into the lumen of cystic formations. Hematoxylin-
eosin staining. Magnification in x100 and x400 respectively 
 
 
Figure 2.17 – Histological examination of the PTC. A. The 
classic version of PTC. B. Pathologic biomineralization of the 
PTC in the form of psammoma bodies. Hematoxylin-eosin 
staining. Magnification in x100 and x400 respectively 
 
In the macroscopic examination, DSvPTC had the 
appearance of solid scar tissue of whitish-grey color. It is 
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expected that in the histological examination this variant of 
papillary thyroid cancer was characterized by a considerable 
amount of connective tissue and constant signs of pathological 
biomineralization in the form of various forms, especially PB 
(Fig. 2.18 A, B). 
 
Figure 2.18 – Histological examination of the DSvPTC. A. The 
diffuse-sclerotic variant of PTC. B. Formation of  psammoma 
bodies. Hematoxylin-eosin staining. Magnification in x100 and 
x400 respectively 
 
The main manifestation of PBM in the tissue of the PTC 
was the formation of PB. They were manifested as rounded 
mineral objects consisting of concentric layers. Today, it is 
generally accepted that the formation of PT from tumor emboli, 
which under the influence of protective mechanisms of the body 
are subject to step biomineralization [39, 40, 55]. This was 
confirmed in histological studies, where the association of PT 
with the vascular component was constantly monitored 
(Fig. 2.19 A, B). Additional evidence of biomineralization of 
tumor emboli and their vasculogenic origin was the detection of 
PT in the collector lymph nodes and distant organ locations 
where they were also associated with vessels (Fig. 2.20 A, B). 
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Figure 2.19 – Histological examination of the PTC. 
Relationship of PB with blood vessels. A. The diffuse-sclerotic 
variant of PTC. B. Formation of psammoma bodies. 
Hematoxylin-eosin staining. Magnification in x100 and x400 
respectively 
 
 
Figure 2.20 – Histological examination of the PTC. 
Relationship of PB with blood vessels. A. PB in the 
subcapsular region of the lymph node. B. PB in a vascular bed. 
Hematoxylin-eosin staining. Magnification in x100 and x400 
respectively 
 
In general, PBs had predominantly intra-tumor 
localization. Most often, it is the stroma of the tumor papillae, 
subcapsular areas, and tumor capsule. There were also an 
infrequent and extracorporeal location of PBs in the connective 
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tissue between follicles or lobules, intact thyroid lobe, and other 
organs, consistent with the notion of an "embolization" theory. 
In order to confirm the presence of calcium compounds 
in the PB PTC, staining with alizarin red according to McGee 
was performed (Fig. 2.21 A, B). 
 
Figure 2.21 – Histological examination of the PTC. A. Positive 
response to Ca2+ compounds in the composition of PB. 
Magnification x100. B. PB with a "calcium background". 
Alizarin red staining, magnification x400 
 
Vascular calcification in the tissue of the PTC is a more 
common pathohistological phenomenon in comparison with the 
follicular cancer of the thyroid gland. In the PTC, lesions of all 
types of vessels occurred: small - capillary type, medium - veins 
and arteries and large (Fig. 2.22). It is also interesting to observe 
the "contact transfer" of biomineralization from the PB to the 
vessel wall. 
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Figure 2.22 – Pathological mineralization in the vessels of the 
PTC. A. Biomineralization of small intra-tumor vessels. 
Magnification x100. B. Biomineralization of the capillary 
vessel. Magnifiation x 400. Staining with hematoxylin-eosin 
 
Larger vessels underwent only partial biomineralization, 
which was limited to the inner or middle layer of the wall 
(Fig. 2.23). With the defeat of the PBM of the large arteries, the 
atherosclerotic origin of the pathology cannot be ruled out. For 
small vessels undergoing biomineralization in the tumor 
parenchyma, this process may be the mechanism of elimination 
(“shutdown”). 
 
 
Figure 2.23 – Pathological biomineralization in the vessels of 
the PTC. A. The lesion of a large arterial vessel. Magnification 
x40. B. Biomineralization of the inner and middle layer of the 
artery. Magnifiation. x400 
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Thus, the major type of pathologic biomineralization of 
the PTC is vascular-dependent calcification, including 
psammoma bodies and vascular calcification. The staining of 
biomineralized objects with alizarin red indicates that they are 
composed of calcium compounds and they are able for reverse 
diffusion. 
 
Morphological and physicochemical analysis of the 
mineral constituent tissue of MTT 
For MTT biominerals, the content of calcium compounds 
was verified in stages: first using histochemical staining 
methods with alizarin red and von Koss stain, then scanning by 
electron microscopes, including microanalysis (EDX), were 
used. Further clarification of the presence of Ca2+ ions was 
carried out by the methods of applied materials science - X-ray 
diffraction (XRD), infrared spectroscopy (IRS), transmission 
electron microscopy (TEM) and X-ray spectroscopy (XPS). 
Sample preparation for SEM was carried out by a 
modified technique, which made it possible to carefully separate 
the inorganic component from the residues of organic matter, 
while maintaining their relative structural integrity. This was 
especially important for the study of pathological 
biomineralization of vessels, where it is difficult to preserve the 
complex architecture of biominerals. 
Thus, in the course of SEM complex fragments of 
mineral substance in the form of prints of vessels and their walls 
were revealed (Fig. 2.24 A, B). Obviously, the retention of the 
form was due to the close adherence to the soft tissues or by the 
mineralization of the organic matrix. The fragment of the vessel 
in the form of a semi-cylinder had an uneven inner surface, 
which can be compared with the "pavement" (Fig. 2.24 A). The 
outer surface of the vessel fragment was smooth, and the 
thickness of this curved plate ranged from a relatively narrow 
range of 10–20 μm. The morphology of the biomineral fragment 
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of the vessel was consistent with the histological structure of 
small vessels of the microcirculatory bed by capillary type. 
 
Figure 2.24 – SEM of biomineral deposits of the follicular 
cancer of the thyroid gland after low-temperature combustion 
(200 °C). A. Biomineral "sample" from a small vessel. B. 
Fragment of the vessel wall. The magnification and the marker 
are indicated at the bottom of the microphoto 
 
Vascular calcification of MTTs (biomineralized vessels 
and PBs) were analyzed using SEM/EDX (Fig. 2.24–2.25). In 
electronic scanners, mineralized elements are manifested as 
bright white-grey objects with signs of destruction in the form 
of fragmentation and cracks, which are related to the 
peculiarities of sample preparation and their cutting at the 
microtome. 
The morphology of PB has been described by us in 
previous works [36, 37]. In this study, PB focuses on the 
relationship and association of these objects with vessels. At 
SEM of the tissue of PTC it was revealed, that PBs were in 
vascular beds of different localization: stroma of papillae, 
capsule, interparticle and interfollicular connective tissue. 
During the passage of the microtomic slice through the tissue of 
mineralized PTC fragments of PB and biomineralized vessels of 
different morphology were revealed, which is mainly caused by 
67 
 
the position of calcified tumor blood clots in the vessels. In 
cross-sections passing through PBs and their blood vessels 
visible laminarity (lamination) structure. In the case of a 
microtome knife, structures in the form of cylinders or cork 
formations were found in the longitudinal plane of the 
biomineralized object. However, in most cases the sections were 
cut at different angles, which led to the destruction and 
decomposition of biomineralized objects (Fig. 2.25 A, B). 
 
Figure 2.25 – Scanning electron microscopy of PTC 
specimens. A, B. Scans of numerous biomineralized vessels 
and PB in specimens of the thyroid gland. The scan mode, 
marker and magnification are indicated at the bottom of the 
microphoto 
 
X-ray diffractograms of the mineralized components of 
the PB-vessel complexes showed a similar chemical 
composition and a high level of their mineralization and 
saturation with calcium and phosphorus (Fig. 2.26). 
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Figure 2.26 – X-ray diffraction spectra of biomineralized 
objects of PTC samples 
 
In addition to the PBs and vessel walls associated with 
them, the SEM and microanalysis of the capsule vessels and 
interstitial stroma with signs of biomineralization were also 
performed. On the scanned scans the vessels had characteristic 
whitish-grey staining, which indicated the presence of 
biomineralization processes (Fig. 2.27 A, B). According to the 
microanalysis of the composition of the surface of the sample 
revealed a high content of calcium (about 40 %), which confirms 
the presence of its biominerals. The level of mineralization of 
these cases was lower than in PB. 
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Figure 2.27 – X-ray scanning electron microscopy of the 
follicular cancer of the thyroid gland with X-ray microanalysis. 
A, B. Biomineralized vessels in the capsule and the inter-
follicular stroma of the tumor. B. X-ray diffractogram of 
mineralized tissue. The green marker indicates the 
microanalysis sections. The magnification and marker are 
indicated in the lower right corner of the mircrophoto 
 
According to diffraction methods (Fig. 2.28–2.29), the 
main crystalline phase of the MTC biominerals is well-
structured hydroxyapatite, often with β-TCMP (beta-three-
calcium-magnesium phosphate) impurities. In the EDX spectra 
of PTC, in addition to the basic lines Ca and P, weak lines S, K, 
Cl and some other elements are often present, which is typical 
for most biominerals of the human body. The intensity ratio of 
the Ca and P lines is close to that characteristic of apatite. 
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The IR spectroscopy data are in good agreement with the 
above structural analysis results and confirm the apatite nature 
of the biominerals (Fig. 2.30). 
 
 
Figure 2.28 – X-ray diffractogram of the biomineral deposit of 
the PTC. The presence of apatite and β-TCMP are present in 
the biominerals 
 
71 
 
 
Figure 2.29 – X-ray diffraction pattern of the biomineral 
deposit of the PTC. Only structured hydroxyapatite is present 
in the biomineral 
 
 
Figure 2.30 – The typical IR spectrum of pathological thyroid 
biominerals 
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The results of TEM and ED confirm the presence of 
apatite in all investigated thyroid deposits (Fig. 2.31). According 
to the TEM, apatite crystals can be of different dispersions and 
sizes (Fig. 2.31 A). The ED pattern shows the polycrystalline of 
pathological biominerals and the features of organization and 
texture of their composition (Fig. 2.31 B). 
Thus, the presented data demonstrate a wide variety of 
sizes, shapes and orientations of calcified crystals of the thyroid 
gland. They confirm their phase attachment to calcium apatites. 
Because the TEM and ED studies do not require a large 
amount of sample material (compared to X-ray diffraction), it 
has made it possible to analyze pathological biominerals of 
different sizes and localization. Also, the results of the study 
gave an opportunity to understand the structural and 
morphological features of biominerals in connection with their 
location in pathological formation or the thyroid gland as a 
whole. 
 
Figure 2.31 – Transmission electron microscopy 
 of nanocrystals (A) and the ED pattern (B) of a sample 
 of biomineral formation 
 
Additionally, X-ray spectroscopy (XPS) was performed 
on specimens of PTC biominerals in which PBs were detected. 
The analysis of the composition of PB with XPS showed that PB 
consists of a large number of chemical elements, but with a 
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predominance of calcium, phosphorus, oxygen and hydrogen in 
the ratios corresponding to hydroxyapatite (Fig. 2.32). This is 
also confirmed by the number of studies described above. 
A very important complement to the XPS results is the 
fact that the PB contains organic components that are of a protein 
nature: the presence of carbon, nitrogen, and oxygen directly 
indicates the presence of protein in the structure of the PB 
(Fig. 2.32 B, D). Evaluation of the results of X-ray spectroscopy 
on the content of calcium, phosphorus and phosphate group 
suggests that the content of hydroxyapatite in PB is 
approximately 80 %. 
 
Figure 2.32 – The composition of PB based on XPS results. 
 A. Artificially stained SEM PB for differentiation of 
constituent elements: blue-stained light elements, red-stained 
heavy elements. B. Chemical composition of PB 
 on phosphorus and calcium fractions obtained from SEM 
microanalysis. B-D. Chemical composition of PB according 
 to XPS results 
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Thus, the following examples of the existence in 
pathological deposits of calcium-phosphate crystalline 
formations of different morphology confirmed by their different 
mechanisms of morphogenesis. This development occurs in an 
inseparable interaction with the organic tissue, forming organic-
mineral aggregates (OMA) of biocomposite type. To a large 
extent, the direction of development of biomineralization and its 
biological function are determined by the organic environment 
and the peculiarities of the pathological process that develops in 
soft tissues. 
High regional incidence of thyroid cancer and other 
thyroid diseases in the Sumy region, and in general, in the North-
Eastern region of Ukraine has long been the focus of attention 
of scientists [136–141]. The peak incidence of thyroid cancer in 
the Sumy region was in 2014–2016, reaching one of the highest 
levels in the world of 11.7–15.1 cases per 100 thousand 
population [41]. 
One of the first attempts to review the role of 
biomineralization in the morphogenesis of thyroid tumors was 
initiated as early as 2004 by Das, but these studies have not 
received the appropriate resonance [54]. However, in the last 
two years, there has been a movement towards rethinking many 
of the established stereotypes of classical thyroidology, 
especially the excessive, “hard” treatment of tumors with 
indolent course. This is due to the fact that the US alone spends 
$ 1.3 billion on the treatment of thyroid cancer and its effects 
[142]. In 2016, a multicenter study was published on the 
reclassification of some types of malignant tumors of the thyroid 
gland (encapsulated follicular variant of the PTC) to a benign 
condition. 
In the same year, a study of Japanese scientists appeared 
about calcification and vascularization of the tumor site in the 
PTC. They found that tumors with intensive blood supply were 
statistically more often larger than tumors with reduced blood 
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supply. Therefore the conclusion is made about the relatively 
benign course of thyroid cancer with the phenomena of 
biomineralization [133]. 
Against this background, there is an increased interest to 
such a poorly researched phenomenon as the biomineralization 
of vascular walls in the tissue of MTC. Vascular calcification 
(VC) is more characteristic as a manifestation of pathological 
biomineralization of the PTC, rarely - the FTC. As already 
noted, under the conditions of the PTC, lesions of all types of 
vessels occur: small - capillary type, medium - veins and arteries 
and large. In addition, assessing PB as a manifestation of VC, 
the interaction of the tumor process and the body emerges in a 
new light. It becomes clear the protective orientation of the 
phenomenon of vascular calcification under the conditions of 
MTC. Probably, similar orientation has VC and at malignant 
tumors of other localizations. 
Another extremely interesting observation is the so-
called "contact transfer" of calcification from the PB to the 
vessel wall, which has been detected in several histological 
preparations. Developing this thought and taking into account 
our previous studies (formation of calcium "halo" around 
biomineralized objects when stained with alizarin red), we can 
assume the possibility of reverse diffusion of calcium ions from 
biomineral deposits, which would create the conditions for the 
spreading of calcification processes to the surrounding tissues. 
VC has a wide variety of manifestations in its detailed 
study. Sometimes monolithic crystals in the form of boulders or 
plates are formed in the walls of vessels. The deposition of 
biominerals occurs in the inner and middle layers of the vessel 
walls, whereby predominantly partial calcification of the cross-
section of the vessel in the limited length section was revealed. 
Small vessels (by the type of venules or arterioles capillaries) 
are characterized by total mineralization of the entire wall, as 
was seen on individual SEM microphotos. Biomineralization of 
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vessels of the microcirculatory bed of the tumor parenchyma 
may be a manifestation of the protective antitumor mechanism 
of the body, so it is a promising area of research in oncology. 
Partial calcification of a large calibre vessel (artery) 
causes some debate regarding the similar localization of 
biomineral deposits in atherosclerotic lesions. However, despite 
the fact that biomineralization is limited to the inner or middle 
layer of the artery wall, the phenomena of lipid deposition or 
formation of atherosclerotic plaques are not observed. 
Thus, the main types of pathological thyroid 
biomineralization are: 
- vascular-dependent calcification, including psammoma 
bodies and vascular calcification, which is more common in 
MTC; 
- stromal calcification, characteristic of the structural 
components of the thyroid gland (lesions of the capsule, 
interparticle and interfollicular connective tissue); 
- parenchymal calcification, characteristic for the 
follicular epithelium and thyroid gland colloid (Fig. 2.33). 
 
Figure 2.33 – The main types of pathological 
biomineralization in thyroid pathology 
 
An immunohistochemical study of VC of MTT was 
performed on the material of the PTC specimens, as this tumor 
mostly characterized by vascular-dependent calcification. In 
Pathological 
biomineralization 
of TG
Stromal 
calcification
Parenchimatous 
calcification
Vascular-
dependent 
calcification
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addition, the proportion of PTC is ¾ of the volume in the 
structure of thyroid disease [38, 41]. 
The study of VC problems also covered the calcification 
of intravascular tumor emboli, which is a substrate for the 
formation of psammoma bodies (PB) and also an integral part of 
the pathological biomineralization of vessels [40, 134]. 
Therefore, in the comparison of the results of 
immunohistochemical study of protein expression in PTC tissue 
with biomineralization (group I) and control samples of PTC 
without mineralization (group II), a significant difference was 
found for proteins - components of calprotectin complex - 
S100A8 (S < 0.001), Casp3 apoptosis markers (p < 0.001), OPN 
biomineralization markers (p < 0.001). For the marker of MPO 
neutrophils and cells of the CD68 macrophage row, no 
significant difference between the parameters of the studied 
groups was found (p > 0.05) (Fig. 2.34). 
 
Figure 2.34 – Results of immunohistochemical study of PTC 
tissue. Evaluation of the intensity of the immunohistochemical 
reaction. * – statistically authentic values (p < 0.05) 
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Thus, the results of immunohistochemical studies for 
PTC have their own characteristics. The presence of significant 
inflammatory infiltration in the stroma of the papillae of both 
PTC groups offsets the difference between the results of these 
groups. Of particular note is the ability of PTC tumor cells to 
secrete OPN. Obviously, only additional stimulation of tumor 
microenvironment cells by biomineral deposits led to the 
preference for OPN expression of mineralized samples over the 
control group. 
The expression of the components of the calprotectin 
complex (S100A8 and S100A9) and Casp3 were significantly 
higher in the group of mineralized PTC, which is consistent with 
the functional meaning of these proteins. It is noticeable that in 
the mineralized tissues of the PTC, the S100A8 and S100A9 
proteins are more often co-localized in the cytoplasm of cells as 
part of the heterodimer calprotectin complex (Fig. 2.35). On the 
other hand, in the PTC control group, the frequency of protein 
expression coincidence is much lower. (Fig. 2.34). However, the 
question of the origin of more S100A8 and S100A9 in the 
mineralized tissues of the PTC remains unclear. If we analyze 
the results of immunohistochemical study (Fig. 2.35 and 2.36), 
we can note the expressed expression of calganulins by tumor 
cells. 
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Figure 2.35 – Immunofluorescence study of the expression of 
S100A8 and S100A9 proteins in I group of PTC tissue, which 
co-localized as calprotectin. Blue is dapi, blue-green – Alexa 
488 (S100A8), yellow-green - Alexa 555 (S100A9), orange is 
calprotectin S100A8 / A9. Magnification x100 
 
Perhaps cancer cells express calganulins to reduce the 
number of calcium ions in their microenvironment as a 
protective mechanism. This question remains open and may be 
a field for further research. 
The presence of the difference between the results of 
immunohistochemical study of the expression of S100A8, 
S100A9, Casp3 and OPN in the 1st and 2nd groups of PTC 
testifies to their role in the processes of pathological 
biomineralization of vessels under conditions of malignant 
tumor process (Fig. 2.36). 
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Figure 2.36 – Immunofluorescence study of S100A8 and 
S100A9 expression in II group of PTC tissue. Blue is dapi, 
blue-green - Alexa 488 (S100A8), yellow-green - Alexa 555 
(S100A9), orange is calprotectin S100A8 / A9. 
Magnification x100 
 
The algorithm for the study of PBM by the methods of 
applied material science for MTC was the same as for the 
biomineral deposits of the cardiovascular system. Initially by 
using histochemical methods, namely by staining with alizarin 
red, identified the presence of Ca2+ ions, then scanning electron 
microscopy, including microanalysis (EDX), was applied. X-ray 
diffraction (XRD), infrared spectroscopy, transmission electron 
microscopy, and X-ray spectroscopy methods have finally 
completed the study of the biomineral phase of MTT 
calcifications. 
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SEM showed the presence of complex fragments of 
mineralized vessels and their walls (Fig. 2.25 A, B). The 
morphology of the biomineral fragment of the vessel was 
consistent with the histological structure of small vessels of the 
microcirculatory bed by capillary type. 
When conducting SEM with microanalysis, it was found 
that the vessels of the capsule and interstitial stroma had a lower 
level of mineralization than the PB in combination with the 
remains of the vessels. 
According to the diffraction methods (Fig. 2.29 and 
Fig. 2.30), it is revealed that the main crystalline phase of the 
MTC biominerals is well-structured hydroxyapatite, often with 
β-TCMP (beta-three-calcium-magnesium phosphate) 
impurities. In the EDX spectra of MTC, in addition to the basic 
lines Ca and P, weak lines S, K, Cl and some other elements are 
often present, which is typical for most biominerals of the human 
body. The intensity ratio of the Ca and P lines is close to that 
characteristic of apatite. 
IR spectroscopy data are also consistent with the results 
of structural analysis and confirm the apatite nature of 
biominerals. 
For the first time X-ray spectroscopy (XPS) was used to 
study PBM of MTC. For this purpose, samples containing only 
PB were selected. In addition to the fact that PBs consist of such 
chemical elements in ratios corresponding to hydroxyapatite 
(Fig. 2.32 A, B), the presence of organic components related to 
the protein nature was established. These data are completely 
new, as well as setting the hydroxyapatite content in PB at 80 %. 
Thus, all cases of thyroid calcification in its most 
common malignant tumors corresponded to calcium-phosphate-
type biomineralization. Structured hydroxyapatites with β-
TCMP impurities were the main phase of biomineral deposits of 
MTC. Also, for the first time, the presence of organic matter 
residues in PB was detected by X-ray spectroscopy. This 
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indirectly confirms our assumptions about the role of the protein 
component (osteopontin) in the formation of the lamellar 
structure of PB. 
  
2.3 Pathological biomineralization in the prostate 
Most scientific papers dealing with the processes of 
pathological biomineralization in the prostate indicate that 
prostatoliths (prostatic lithiasis) are formed by dystrophic 
calcification of starch or amyloid bodies (Latin name – Corpora 
amylacea - CA), mainly formed in the lumen of glands of 
amyloid proteins [143]. This theory was started in 1861 when it 
was proposed by Sir Henry Thompson. 
This view of the genesis of amyloid bodies and 
prostatoliths, as different stages of the same process, has many 
adherents among modern researchers [145]. According to 
Thompson's theory, desquamated epithelial cells give a start to 
the processes of concernments formation. They are nucleation 
cores on the basis of which the amyloid bodies are formed in the 
protein-rich prostatic fluid. It was believed that these little 
bodies acted as foreign bodies, which provoked an inflammatory 
response. Calcium ions and phosphates from degenerating 
epithelial cells were incorporated into amyloid bodies [144]. In 
general, the theory was accepted, only discussions were held on 
the mechanisms of CA calcification. Some authors guess the 
formation of prostatoliths by two related mechanisms. The main 
essence in both cases is obstruction and stagnation of the 
prostatic fluid [145]. Addition of the inflammatory response in 
conditions of stagnation of the secretion initiates and intensifies 
the processes of biomineralization [146]. 
Obtaining the most complete picture of the origin and 
maturation of prostatoliths is not possible without a detailed 
study of the concretions and surrounding soft tissues of the 
prostate. In addition, to understand the phase composition of 
deposits, the size and prevailing shape of crystals, the structural 
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and concentration features of the formed biominerals, it is 
necessary to study the conditions that lead to biomineralization. 
For this purpose, the prostate material with signs of diffuse 
benign prostate hyperplasia (BPH) without the presence of 
prostatic lithiasis (first group) and BPH with the presence of 
calcifications (second group) was investigated. 
Both groups of BPH samples during histological 
examination were characterized by the presence of secretion, the 
phenomenon of stagnation, amyloid bodies in the enlightenment 
of the prostatic glands, and inflammatory infiltration around 
them. It should be noted that the predominance of these features 
was observed in the group of BPH samples with prostatic 
lithiasis. 
Immunohistochemical study showed certainly higher 
expression in group I of prostate samples for markers of cells of 
the CD68 macrophage row (p < 0.001), components of 
calprotectin complex - calgranulins A (S100A8 - p < 0.001) and 
B (S100A9 - p < 0.001), markers of apoptosis Casp3 (p < 0.01) 
and OPN biomineralization marker (p < 0.05). For the MPO 
neutrophil marker, no significant difference between the groups 
studied was found (p > 0.05). 
Despite the difference between the two groups 
compared, a relatively high level of inflammatory cell marker 
expression and apoptotic activity should be noted in the control 
group. 
The number of S100A8- and S100A9-positive cells is 
also higher in prostate tissue with biomineral concrements, but 
compared to other mineralized tissues, the rate of formation of 
the calprotectin complex is lower (Figs. 2.37–2.38). 
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Figure 2.37 – Immunofluorescence study of S100A8 and 
S100A9 protein expression in group I of BPH tissue. Blue is 
dapi, blue-green - Alexa 488 (S100A8), yellow-green - Alexa 
555 (S100A9), orange is calprotectin S100A8 / A9. 
Magnification x200 
 
In a detailed study of the location of 
immunofluorescence antibodies against calgranulins A and B, it 
was observed that they are expressed separately or as part of the 
calprotectin complex in the papillary folds of the epithelium of 
the glands and in the lumen of small vessels (hemocapillaries). 
The presence of co-localization of S100A8 / S100A9 in 
prostatosomes, that separate from the apical part of 
epitheliocytes into the lumen of the glands, is constantly noted, 
forming a high intraluminal concentration of these proteins. This 
apparently results in the presence of calganulin B in prostatolite 
extracts, which was confirmed by Western blotting. Bands of 
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S100A9 protein were present in all specimens of prostate stones 
(Fig. 2.39). Another interesting phenomenon, which is often 
repeated, is a large number of calprotectin complex in the basal 
part of the cytoplasm of the prostate epithelium (Fig. 2.38 B). 
The value of the "basal accumulation" of calprotectin remains 
incomprehensible and needs an in-depth study. 
 
 
Figure 2.38 – Immunofluorescence study of S100A8 and 
S100A9 protein expression in group I of BPH tissue. 
A. Prostatosomes containing calprotectin. Magnification x400. 
B. S100A8- and S100A9-positive cells are present in the 
stroma of the papillary folds of the epithelium of the glands 
and in the capillaries. Magnification x200. Blue is dapi, blue-
green – Alexa 488 (S100A8), yellow-green – Alexa 555 
(S100A9), orange is calprotectin S100A8 / A9 
 
86 
 
 
Figure 2.39 – Western blot of prostatolith extracts (1–2 lines) 
and amyloid bodies (3–7 lines) with luminescent antibodies 
against S100A9 protein. Line 8 – S100A9 Protein Control 
Solution. Molecular markers of proteins are shown in red on 
the membrane. Bands of calgranulin B are located in the lower 
part of the membrane in the region of 12–15 Kd 
 
In the control group of BPH samples, the expression of 
S100A8 and S100A9 proteins was markedly lower, although it 
was also present at a stable level. The presence of these proteins 
in the enlightenment of the capillaries the basal parts of the 
epitheliocytes was also noted. The bright fluorescence of 
amyloid bodies was revealed, which is largely due to the 
autofluorescence of the proteins that make up its composition 
(Fig. 2.40). 
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Figure 2.40 – Immunofluorescence study of S100A8 and 
S100A9 protein expression in group II of BPH tissue. Blue is 
dapi, blue-green – Alexa 488 (S100A8), yellow-green – Alexa 
555 (S100A9), orange is calprotectin S100A8 / A9. 
Magnification x200 
 
The fluorescence localization of calgranulins A and B in 
the prostate tissue was correlated with inflammatory infiltrate 
and circulating inflammatory cells (CICs) around the glands, in 
the small vessels lumen, and in the connective tissue component. 
It is also apparent that the presence of prostatoliths supports the 
inflammatory process and promotes desquamation of the 
prostatic epithelium (increased Casp3 expression), which is the 
source of building materials for biomineral deposits. 
In addition to the fact that OPN is "attracted" by the 
presence of biomineral deposits in tissues (in this case – 
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prostatoliths), this protein is characterized by a certain level of 
expression in the inflammatory infiltrate [86, 118]. 
The difference between the results of the 
immunohistochemical study of the expression of CD68, 
S100A8, S100A9, Casp3 and OPN in the 1st and 2nd groups of 
BPH samples indicates their role in the processes of prostatoliths 
formation under benign prostatic hyperplasia. 
According to the PEM data (Fig. 2.41 A), crystals of 
pathological prostate deposits have mostly irregularly rounded 
shape with average sizes of several tens of nanometers with a 
monomorphic composition of crystalline particles. The 
surface/volume ratio of prostate nanocrystals indicates a 
significant area of interaction with the organic component or 
biological fluid of the luminal section of the prostatic glands.  
 
Figure 2.41 – Investigation of prostatoliths using TEM and ED. 
A. Electron microscopic images of crystalline prostatoliths 
particles. Magnification x40 500. B. Typical electron 
diffraction pattern on prostate calcite crystals. On the right – 
are the crystallographic indices of hkl apatite 
 
In general, the beginning of the mechanism of formation 
of intraluminal inclusions of the prostate should start with age-
related changes of the organ. Remodeling of the prostate tissue 
under the influence of age is characterized by hyperplasia of the 
fibro-muscular component, which leads to compression of the 
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glands and their ducts, complication of drainage of the secretion 
from the prostate, formation of the phenomena of stagnation. 
Retention of gland secretion or urine reflux into the tissue of the 
prostate in case of difficulty in urination, causes the 
development of inflammation. On histological preparations it is 
noticeable that the inflammatory infiltrate, as a rule, is localized 
around the glands. Against the background of focal mixed-cell 
inflammatory infiltration and congestion, the "thickening" of the 
secret, the formation of starchy little bodies - corpora amylacea 
is often noted. The staining of histological sections of the 
prostate by the corpora amylacea with Congo red confirms the 
amyloid nature of CA. CAs further contribute to the deepening 
of congestion, impeding the drainage of prostatic content. 
In our previous study of intraluminal inclusions at BPH, 
it was found that prostatoliths were showed up in  
27.6 ± 3.48 % among the histological specimens studied. 
Despite the frequent combination of the investigated features in 
patients with prostatolithiasis, no significant correlation was 
found between the presence of stones and CA in the prostate. A 
strong correlation was found between inflammation, stagnation 
and the formation of concrements, indicating the important 
etiopathogenetic role of these factors for prostatolithiasis [43]. 
These data allow us to better understand the mechanism of 
formation of prostatic calculi in the prostate. 
According to electron diffraction (ED), infrared 
spectroscopy (IRS) and scanning electron microscopy with X-
ray microanalysis (SEM / EDX), carbonate bioapatite with a 
high probability of minor inclusions has been found to be the 
mineral base of prostate concretions. PEM results show the 
morphological uniformity of crystalline particles of prostatic 
calculi and their size (tens of nanometers) is quite small. This is 
a testimony to their predominant formation by direct 
precipitation with calcium and phosphate supersaturated 
biological solutions than the origin and maturation on the surface 
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of biological tissues (in this case, corpora amylacea). Given the 
presence of carbonate substitutions according to the IRS, it is 
likely that pathologic calcifications of the prostate are not phase 
"pure" calcium apatite, but refer to apatites that have isovalent 
and heterovalent substitutions in the cationic and anionic 
lattices. However, the considerable concentration of zinc in the 
material of concrements does not allow to fully attribute it to the 
crystalline lattice of apatite (cationic substitution), but rather 
indicates a preferential stay in the non-apatite component of the 
deposit. In general, the presence of zinc is easily explained by 
its essentiality, tropism to the prostate, by the presence of 
coenzyme in many enzymes. 
In our study, prostatic calculi with internal localization 
in the organ - prostatic glands or fibrotic tissue of the prostate - 
were selected for the material study. The concrements that could 
have come from the urinary system (prostatic part of the urethra) 
were not detected. This is explained by the fact that no prostatic 
calculi was found in the study, which consisted of oxalates, 
urates or other salts characteristic for the urinary system. The 
irregular rounded shape of the prostatoliths is due to their forced 
placement in the lumen of the glands of the prostate, and the 
stratification of the structure and the different size of the layers 
of mineral matter indicate the cyclical course of the pathological 
process with exacerbations and periods of remission. It seems 
that in the periods between the formation of the biomineral 
layers of the prostatoliths, proteins and microelements from the 
environment of the prostate enlightenment, which were "closed" 
between the hydroxyapatite plates of the concretions, were 
included in the concretions. It is this type of protein deposition 
that is detected during atomic force microscopy (AFM) and 
during the Western blot analysis. 
Considering the results of pathomorphological 
examination and the data of physical material science, it can be 
concluded that the precipitating mechanism of concrement 
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formation in the prostate is the direct precipitation from the 
secretion of the prostate, and not the dystrophic calcification of 
starchy bodies. 
The mineral basis of prostate concretions is carbonate 
bioapatite with little incorporation of foreign chemical elements. 
Thus, the stability of the form and mineral composition 
of prostatoliths in all the tested samples testifies to the similarity 
of the mechanisms of formation of concrements and the 
regulation of the process of biomineralization in the prostate. 
The obtained results have allowed us to propose the following 
scheme of formation of a “circulus vitious” which arises at 
development of pathological biomineralization in a prostate (fig. 
2.42) 
 
Figure 2.42 – The scheme of " circulus vitious" in prostatic 
lithiasis 
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2.4 Pathological biomineralization of the gallbladder 
Among the diseases of the gallbladder, which 
accompanied by manifestations of pathological 
biomineralization, the most common are gallstone disease, 
which is manifested in the wall of the gallbladder with signs of 
chronic cholecystitis, carcinoma of the gallbladder with 
calcifications and the so-called porcelain gallbladder (PGB) 
[147]. Clinical importance of pathological biomineralization of 
the wall of the porcelain gallbladder is that it is associated with 
gallbladder cancer (GBC) in 12-62 % of cases [148, 149]. 
PGB is a rare manifestation of chronic gallbladder 
disease and is characterized by massive calcification throughout 
the wall and occurs in 0.06-0.8 % of cholecystectomies [150]. 
The causes of PGB are unknown. The porcelain gallbladder was 
first described in 1929 [149]. Pathology is more common in 
women than in men (5: 1 ratio). The age of most patients ranges 
from 50 to 70 years [151, 152]. Perhaps this reflects the overall 
statistics, because the disease of the GB, and directly gallstone 
disease are more common for women. PGB is believed to be a 
complication of chronic cholecystitis due to prolonged 
inflammation. This is confirmed by the fact that the prevalence 
of PGB increases with age and disease duration over 10 years 
[153]. 
There are two types of porcelain gallbladder, depending 
on the degree of calcification: full (occupies the entire organ, 
pierces the muscular layer) and incomplete (multifocal, dot 
deposits) [154]. 
Important is the issue of differential diagnosis of 
gallbladder adenocarcinoma with numerous dotted intracellular 
calcifications and incomplete type of porcelain gallbladder. It is 
believed that intracellular calcification of the GB is due to 
dystrophic calcification of the tumor necrosis foci. It is the 
reduction of metabolism and carbon dioxide that leads to a 
localized alkaline environment that causes mucin glycoproteins 
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to behave as ion exchange resins. This factor can cause the 
deposition of calcium compounds [155]. Most reports of 
calcified adenocarcinoma of the internal organs and gallbladder 
have been presented with a mucinous type of adenocarcinoma 
with multifocal, point calcifications, which are usually localized 
at sites of mucus accumulation. 
Historically, perceptions of the relationship between 
PGB and the risk of cancer of the GB have changed. The first 
works of the 60–70's of the XX century. described a rather high 
incidence of malignancy (malignant degeneration) of PGB – up 
to 62 % [148, 153, 155]. Recent studies have shown that the 
incidence of carcinoma on the background of PGB ranges from 
0 % to 5 % [154]. Some studies indicate that the full type of PGB 
is not associated with cancer of the GB [153]. 
The results of our study and the literature review data can 
be presented in Table 2.1 [156]. 
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Table 2.1 – Pathohistological features of forms of 
gallbladder calcification 
 
Indicator Chronic 
calculous 
cholecystitis 
Gallbladder 
cancer with 
calcines 
Porcelain 
gallbladder 
Size Unchanged Often increased Reduced in 
size 
Wall 
thickness 
Slightly thickened Thickened Thickened 
Microscopic 
description 
In the wall of the 
GB can be 
distinguished 
layers of the usual 
structure, fibrotic 
changes, 
hyalinosis, intense 
mixed-cell 
inflammation  
of the mucous 
membrane 
The gallbladder 
wall is fibrous, 
hyalinized with 
atypical glandular 
structures that 
grow invasively 
The amount  
of cellular 
elements, 
massive 
deposits  
of small and 
large 
fragments  
of biominerals 
are sharply 
reduced in the 
wall of PGB 
Localization 
of 
calcifications 
In the cavity (in 
the form  
of stones), rarely 
in the walls as 
single foci 
In the walls of the 
organ (in the 
tumor), it looks 
like a single 
focuses 
The walls are 
totally 
calcified,  
a continuous 
layer, 
sometimes 
occupying the 
whole organ 
The 
composition 
of minerals 
calcium 
carbonate, 
dolomite 
hydroxyapatite hydroxyapatite 
Fibrosis moderately 
expressed 
expressed expressed 
Hyalinosis moderately 
expressed 
expressed expressed 
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Morphological and physicochemical analysis of mineral 
component of gallbladder tissue in its pathology 
The study of the mineral component of the gallbladder 
tissue was carried out according to the scheme adapted to the 
situation: soft tissue staining with available biomineral 
component by alizarin red, scanning electron microscopy (SEM) 
of a section of mineralized tissue with X-ray microanalysis 
(SEM / EDX), X-ray diffraction (XRD) of mineralized 
fragments and atomic force microscopy (AFM) examination. 
The study of the biomineral component of the 
pathological tissue of the GB was complicated by the small 
content of the GBC tissue, which could not be isolated in 
quantities sufficient for x-ray diffraction and other methods of 
applied material science. The determination of the crystalline 
phase for GBC was performed by examining tissue sections 
using SEM with microanalysis. On the other hand, the soft tissue 
of the wall of the GB with the effects of gallstone disease did not 
contain a mineral component. The study of the crystalline phase 
was carried out on calcium-containing concretions of the cavity 
of the GB by means of x-ray diffraction of their ashes. 
Scanning electron microscopy of specimens of PGB wall 
showed massive deposits of biomineral matter in the tissue. 
These calcifications, according to EDX, consisted of calcium 
and phosphorus (Fig. 2.43) with a ratio of 1.4–1.6:1, which 
corresponds to the structure of hydroxyapatite [157]. 
In the study of the wall of the gallbladder with GBC 
using SEM revealed one foci of calcification with uneven edges, 
closer to rounded. Energy-dispersive x-ray analysis of the 
detected biomineral deposit showed a predominance of calcium 
and phosphorus with a ratio of 1.6: 1, which also corresponds to 
the structure of hydroxyapatite (Fig. 2.44). 
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Figure 2.43 – Scanning electron microscopy with 
microanalysis. A. Slice of PGB tissue. The location of the 
microanalysis is indicated by a red label. X-ray diffraction 
pattern of the mineral component. The magnification and 
marker are indicated in the lower right corner of the 
microphoto 
 
 
Figure 2.44 – Scanning electron microscopy with 
microanalysis. A. Slice of PGB tissue. The location of the 
microanalysis is indicated by a red label. X-ray diffraction 
pattern of the mineral component. The magnification and 
marker are indicated in the lower right corner of the 
microphoto 
 
In the study of the biomineral component of PGB by 
means of X-ray diffraction of samples (Fig. 2.45), full 
compliance with the structural data of hydroxyapatite (Ca10 
(PO4) 6 (OH)2, JCPDS No. 9-0432) was established. 
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Significant expansion and overlapping of diffraction 
peaks indicates a low degree of crystallinity of the material 
under study. The estimation of the crystallite size according to 
Scherrer [157] shows very close values to the typical size of 
bone crystallites. It is necessary to note some elongation of 
crystals of hydroxyapatite, which speaks of their similarity to 
lamellar or rod-like morphology characteristic of bone tissue or 
similar synthetic materials (Fig. 2.45). 
 
 
Figure 2.45 – X-ray diffraction patterns of biominerals of the 
gallbladder wall; the vertical lines correspond to the angular 
positions and relative intensities of the lines by JCPDS 
standard No. 9-0432 
 
Structural studies of cavity concretions in gallstone 
disease of the gallbladder showed that the main crystalline phase 
of the biomineral deposit is calcium carbonate (CaCO3, JCPDS 
No. 83-577 or/or JCPDS No. 88-1810), which was characterized 
by a high degree of crystallinity (Fig. 2.46). 
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Figure 2.46 – X-ray diffraction patterns of pathological mineral 
formations inside the GB; the left arrow indicates the strongest 
line of additional calcium-phosphate phase (- (Ca, Mg)3 
(PO4)2 and/or apatite, right: * calcite line, JCPDS No. 88-1810, 
v – vaterite line, JCPDS No. 74-1867 
 
In addition to calcium carbonate, in some samples other 
structural phases and forms of calcium carbonate, such as β-
tricalcium magnesium phosphate (Ca, Mg)3(PO4)2, dolomite, 
vaterite (JCPDS No. 74-1867), calcite (JCPDS) were also found 
in trace amounts (several percents). No. 88-1810). 
The results of the study of crystalline phases of the 
gallbladder are shown in Table 2.2. 
Atomic force microscopy of tissue sections was applied 
to study morphology and the three-dimensional properties of the 
biomineral component of the walls of the PGB and the GBC. For 
PGB, it was found that even at the nanoscale level, the fiber 
structure of biomineralized tissue remains, which also forms a 
mesh structure (Fig. 2.47 A). Another unexpected result of the 
study of the biominerals of PGB was the detection of 
extraordinary durable properties of this tissue - about 120 GPa, 
which is higher than many metals and synthetic materials. The 
high adhesiveness of this pathobiological material was also 
detected. 
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Table 2.2 – The results of the study of the phase 
composition of GB biominerls 
Case Age Sex Pathology The crystalline 
phase of the 
mineral 
1 58 F PGB HA 
2 59 F PGB HA 
3 60 F PGB HA 
4 64 F PGB HA 
5 66 F PGB НА 
6 48 F ChC Calcite, TCMP 
7 50 F ChC Calcite, TCMP 
8 52 F ChC Calcite, vaterite 
9 55 F ChC Calcite, vaterite 
10 55 F ChC Calcite, dolomite 
11 60 F ChC Calcite, dolomite 
12 62 F ChC Calcite 
13 63 F ChC Calcite, dolomite 
14 48 F ChC Calcite, vaterite 
15 51 F ChC Calcite 
16 57 M GBC HAP 
17 58 F GBC HAP 
18 70 F GBC HAP 
19 75 F GBC НАP 
20 78 F GBC НАP 
Notes. HAP – hydroxyapatite, TCMP – tricalcium magnesium 
phosphate 
 
The biominerals that were found in the tissue of GBC 
were objects of amorphous structure, with rounded layers 
(Fig. 2.47 B). They had a rather high adhesiveness of the 
material, but the durability of the "cancer" biominerals was 
much lower (about 3 times - about 40 GPa). 
100 
 
 
 
Figure 2.47 – Investigation of pathological gall bladder 
biominerals by atomic force microscopy. A. An image 
 of a 5-nm area of the surface of the PGB biomineral. 
 B. An image of a 5-nm area of the surface of the GBC 
biomineral 
 
Of course, such results of AFM are encouraging, in terms 
of possible study of the development of a new type of 
biocomposite synthetic materials for industry and medicine. 
However, these results were obtained: 1) for the first time; 2) on 
a limited number of samples. Further studies with a sufficient 
number of samples for statistical processing are required to 
establish the fairness or inaccuracy of the results obtained and 
their reproduction. 
Thus, different topology and conditions of formation of 
biominerals in the pathology of GB lead to the formation of 
different crystalline phases and/or different structural 
organization of the biominerals of the investigated organ. This 
indicates directly different mechanisms of development of 
pathological biomineralization. For example, "wall" biominerals 
are represented by hydroxyapatite and "cavity" by calcium 
carbonate with phosphate impurities. In addition, even among 
hydroxyapatites that form in the wall of the GB, different causes 
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and conditions of development lead to different structural and 
physical properties of biominerals. 
A detailed study of the pathological biominerals of GB 
using additional methods of applied material science showed 
their different mineral composition. X-ray diffraction an alysis 
of the mineral deposits of the PGB wall revealed the presence of 
hydroxyapatite. Calcium-containing concretions of GB, 
according to the results of material research, consisted of 
calcium carbonate, in the presence of other trace amounts of 
calcium phosphate phase (vaterite, dolomite). The difference in 
the mineral composition of biominerals may be due to different 
conditions and mechanisms of their formation. Obviously, in the 
wall and cavity of the GB, there is a difference in the 
environment, pH, as well as the impact of various pathological 
processes. There is a large amount of sodium bicarbonate in bile 
as part of the powerful buffer system characteristic of this part 
of the gastrointestinal tract. It is obvious that it is the excess of 
bicarbonate ions that causes the formation of calcites in the 
cavity of the GB. One of the possible causes of pathological 
biomineralization in the gallbladder wall may be the lack of 
phosphorus in the internal environment of the gallbladder and 
the specificity of the conditions of formation of biominerals on 
the wall and in the cavity of the GB. 
Paying attention to the peculiarities of the biological 
consequences and directionality of the processes of pathological 
biomineralization in the tissues of the GB, it should be noted 
that, among 5 clinical cases of PGB, no signs of malignant tumor 
growth or phenomena of any proliferative activity of the 
epithelium or other cells were detected. Therefore, based on the 
results of our own research and analysis of literature, we can 
conclude that the widespread (total) biomineralization of the GB 
has no clear connection with the emergence of malignant 
tumors. On the other hand, small foci of calcification in the wall 
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of the GB are a prognostic sign of possible association with 
GBC. 
The different crystal-chemical characteristics of the 
mineral deposits of the wall of the PGB and the stones of the 
cavity of the GB indicate different conditions, causes and 
mechanisms of their formation. Different topology and 
formation conditions lead to the formation of different 
crystalline phases and/or different structural organization of the 
biominerals of the GB. This indicates directly the versatile 
mechanisms of development of pathological biomineralization. 
For example, "wall" biominerals are represented by 
hydroxyapatite and "cavity" by calcium carbonate with 
phosphate impurities. In addition, even among hydroxyapatites 
which form in the wall of the GB, polyetiology and 
developmental conditions lead to different structural and 
physical properties of biominerals. 
We should highlight promising line of research of 
biomineralization processes of the fibers of the wall of the GB 
under the conditions of development of PGB. A deeper and 
numerical study of this problem may lead researchers to develop 
a new type of biocomposite synthetic materials for industry and 
medicine. 
 
2.5 Pathological biomineralization in other organs 
In all the investigated cases, the structural-phase and 
chemical analysis of pathological biominerals of the thyroid 
gland corresponded to calcite. It should be noted that calcite in 
the human body is formed only in the inner ear (otoliths, normal) 
and gallbladder (part of the stones, pathology). In other tissues, 
hydroxyapatite is predominantly formed [29, 31, 33, 37, 43, 49, 
53]. The main reason for the formation of calcite in the tissues 
of the thyroid gland is the presence of a large number of 
bicarbonate ions there, which is the determining building 
material for pancreatitis [158]. 
103 
 
Therefore, the study found that the presence of 
pancreatitis is accompanied by significant morphological 
remodeling of the thyroid gland. Histological examination of the 
thyroid gland revealed signs of chronic pancreatitis, fibrosis, 
atrophy and edema of the glandular tissue, systemic enlargement 
of the ducts of the gland, focal mixed-cell inflammatory 
infiltrates, plethora of blood vessels. The main crystalline phase 
of pancreatitis was calcium carbonate in the form of calcite. 
Structural-phase and chemical composition of the eye 
biomineral was established using the methods of applied 
material science. The presence in the pathological formation of 
the apatite crystalline phase with relatively small crystallite sizes 
with a defective crystalline lattice is quite typical in many cases 
of ectopic biomineralization. 
Thus, during the pathomorphological study of the 
biominerals of the eye, salivary, pancreas and mammary glands, 
some common features were identified. With the exception of 
pancreatitis, which is characterized by the presence of calcite, all 
the concretions were calcium-phosphate-type biomineralization, 
namely, they were represented by hydroxyapatites. For 
malignant ductal tumors of the salivary and mammary glands, a 
similar mechanism of mineral formation was observed, which 
was conditioned by ductal localization of tumors and the 
presence of a large amount of necrotic tissue in the parenchyma 
of tumors. 
Since the biomineralization of soft tissues of living 
organisms is at the intersection of many scientific fields and 
areas, there are some difficulties in the systematization of the 
knowledge gained, due to a large amount of diverse information 
available. Traditional perceptions of biomineralization in soft 
tissues have been based on the predominance of general or local 
factors in the mechanisms of its development and the widespread 
perceptions of molecular and cellular interactions in the foci of 
occurrence of calcifications in previous decades. Thus, 
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metastatic, dystrophic and metabolic calcifications were 
distinguished. The widespread ectopic calcification arising on 
the basis of systemic disturbance of mineral metabolism was 
defined as metastatic calcification. It has been associated with 
the onset of hypercalcemia, which has evolved for a variety of 
reasons, and the subsequent fallout in the tissues of "excess" 
calcium compounds from biological fluids. If hypercalcemia 
was absent, ectopic biomineralization was defined as dystrophic 
calcification. It was the result of damage, disease, death or 
ageing of soft tissues. Dystrophic calcification has previously 
been thought to be characterized by the deposition of calcium 
compounds in tissues that are in a state of necrosis or deep 
dystrophy. The mechanism of dystrophic calcification was 
described as follows: destructive tissues are a source of 
phosphatases and alkaline environments. It should be noted that 
ossification, which is sometimes found in the same diseases, is 
also considered a manifestation of dystrophic calcification. 
In cases where the explanation of the causes and 
mechanisms of biomineralization was difficult, the metabolic 
type of calcification was additionally highlighted. Thus, 
metabolic calcification was referred to as the so-called "lime 
gout", a disease of unknown etiology, which was associated with 
the instability of the body's buffer systems. 
In recent years, many new mineralization factors have 
been explored and existing mechanisms of this process have 
been identified and refined. In numerous works on 
biominerology, an active focus and adjustability of biological 
mineralization processes have been established, and numerous 
factors of the cellular, molecular and metabolic environment of 
this process have been discovered. 
Summarizing the results of our study of 
biomineralization of soft tissues under various causal and 
topographic conditions, we can distinguish the main points of 
pathological biomineral formation in human organisms. 
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According to the results of our research, pathological 
biomineralization develops by two main physical and chemical 
mechanisms: matrix deposition of biomineral deposits and direct 
deposition of biomineral compounds from a supersaturated 
solution. Matrix biomineralization can be divided into 
parenchymal and stromal, as it occurs in the presence of a 
surface for deposition. Such a surface can be easily found in 
most internal organs and vessels. The presence of a large number 
of stromal elements such as connective tissue, small vessel 
walls, nerve sheaths, and parenchyma elements such as cell 
membrane fragments, organelles, nuclei (apoptosis and necrosis 
effects) create all the necessary conditions for the development 
of biomineral formation. This way biominerals in the walls of 
the aorta, aortic valves, eyes, thyroid gland, lungs are formed. 
 
 
Figure 2.48 – Classification of pathological biomineralization 
of soft tissues by predominant physico-chemical mechanism 
and topography of biominerals 
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Formation of biominerals by a deposition mechanism is 
characteristic of "cavity" biomineralization. Favorable 
conditions for the formation of biominerals are present in 
biological cavities with limited or semi-open contours and filled 
with a biological fluid with a high content of "building material" 
for biomineralization. This mechanism is characteristic for the 
formation of prostatoliths, gallstones, pancrealiths and sialolites. 
Our studies also showed the presence of an intermediate variant 
of the development of the biomineralization process (Fig. 2.48). 
This variant is characteristic for intraductal malignant 
tumors of the mammary and salivary glands. Intraductal gland 
cancer is characterized by the presence of comedo necrosis, 
which is actually formed in the lumen of the duct system. Over 
time, comedonecrosis undergoes biomineralization of the 
parenchyma by matrix type. 
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CONCLUSION 
 
For over a billion years, biomineralization processes 
have provided living organisms with the conditions for 
locomotion, support, protection against predators, and even act 
as weapons. The formation of biominerals has undergone 
changes along with the evolutionary process. Of course, like any 
useful compensatory-adaptive reaction, biomineralization has a 
pathological reflection: many diseases are complicated by its 
excessive or untimely manifestations. 
The study of biomineralization should aim to study the 
significance of this process for conditions of physiological norm 
and pathology. Only after that, it is necessary to develop ways 
to prevent, block or stimulate them. This is because in many 
cases the development of biominerals is a protective reaction of 
the body to damage by a pathogenic factor, so inhibition of 
biomineralization in some cases (complicated atherosclerosis, 
papillary thyroid cancer, osteoblastic bone metastases) can cause 
new pathological processes or complications of the disease in 
the body. 
In most cases, the development of PBM causes 
significant harm to the body, significantly reducing the quality 
and life expectancy of patients. For such pathological processes 
it is necessary to study in detail the mechanisms of mineral 
formation in living tissues and to develop ways of preventing 
and blocking the development of "pure" pathological 
biomineralization. 
A detailed study of the processes of biomineralization of 
soft tissues will allow us to take a fresh look at many established 
ideas about this process. New knowledge gained during the 
research stimulates the development of many promising areas in 
medicine, molecular biology and biotechnology of new 
materials. Thus, the presence of high levels of expression of 
certain proteins, and especially fragments of their micro-RNA 
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and DNA, will make it possible to diagnose and clarify the stage 
of major general pathological processes (malignant tumor 
growth, atherosclerosis) even before the appearance of 
widespread clinical manifestations. On the other hand, detection 
of the fact of directed elimination of intratumoral vessels by 
means of biomineralization processes will allow to start 
searching for targeted medicines for antitumor chemotherapy. A 
separate line should be allocated to the possibilities of research, 
isolation from the biological environment and synthesis of new 
promising biocomposite materials. Biological prototypes of this 
kind of materials occur at different stages of the development of 
biomineralization processes. For example, mineralized fibers of 
the wall of the porcelain gallbladder have extraordinary 
mechanical properties (durability, adhesion, hardness). 
Mineralized aortic tissue and valves show interesting data. 
The prospect of searching for new biomarkers, chemical 
products, biocomposite materials will allow to reveal at the 
present level the relevance and further development of studies of 
biomineralization processes in living organisms. 
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